Pollen allergy

POLLENALLERG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J30.10, J30.19 Cause of death: ICD-10 — J30.10, J30.19 2 out of 7 registries used, show all original rules.	10408
4. Check minimum number of events None	10408
5. Include endpoints None	10408
6. Filter based on genotype QC (FinnGen only)	9409

Control definitions (FinnGen only)

Control exclude: ASTHMA_ALLERG

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	POLLENALLERG
CONTROL_EXCLUDE	ASTHMA_ALLERG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pollen allergy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	108129	50206	57693
Only index persons	94109	45353	48756
Unadjusted period prevalence (%)
Whole population	1.53	1.44	1.61
Only index persons	1.77	1.67	1.86
Median age at first event (years)
Whole population	14.16	17.11	11.52
Only index persons	16.22	19.74	12.94

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9409	6455	2954
Unadjusted period prevalence (%)	2.00	2.29	1.35
Median age at first event (years)	31.74	32.71	29.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9860: Matched controls
97190

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03DC03

ATC

montelukast; oral

5.8

307.7

3864

9711

J45.0

ICD-10 Finland

Predominantly allergic asthma

16.4

307.7

3944

3791

R06AX27

ATC

desloratadine; oral

4.9

307.7

6095

24164

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

6.0

307.7

2499

5202

R01BA52

ATC

pseudoephedrine, combinations; oral

2.4

307.7

3030

14929

R06AX13

ATC

loratadine; oral

4.3

307.7

3187

9767

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

5.6

307.7

3649

9218

R03BA05

ATC

fluticasone; inhalant

4.3

307.7

3493

11076

H02AB06

ATC

prednisolone; systemic

3.5

307.7

5756

28032

R06AE07

ATC

cetirizine; oral

5.1

307.7

7231

34028

R03AC03

ATC

terbutaline; inhalant

4.0

307.7

2331

7050

R01AD01

ATC

beclometasone; nasal

3.1

307.7

2042

7581

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

5.5

307.7

847

1640

R01AC01

ATC

cromoglicic acid; nasal

5.3

307.7

973

1954

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

4.9

307.7

1070

2361

E0000UV, ,

ATC

2.4

307.7

5206

31342

XG410

NOMESCO Finland

Flow-volume spirometry

8.0

307.7

818

1081

R97

ICPC

Allergic rhinitis

6.7

307.7

816

1285

R03BA02

ATC

budesonide; inhalant

4.6

307.7

3391

10002

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

307.7

355

R01AD05

ATC

budesonide; nasal

4.8

307.7

1347

3078

J45.8

ICD-10 Finland

Mixed asthma

7.0

307.7

645

956

R01AD09

ATC

mometasone; nasal

3.8

307.7

6788

35513

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

97.3

307.7

479

R03BA08

ATC

ciclesonide; inhalant

3.6

307.7

1319

4000

A92

ICPC

Allergy/allergic reaction NOS

4.6

307.7

947

2197

L27.2

ICD-10 Finland

Dermatitis due to ingested food

9.5

307.7

560

614

R03AK07

ATC

formoterol and budesonide; inhalant

2.9

307.7

3100

13308

J45.9

ICD-10 Finland

Asthma, unspecified

4.9

307.7

3490

9733

XQ800

NOMESCO Finland

Prick test

9.8

307.7

3034

4200

T78.4

ICD-10 Finland

Allergy, unspecified

4.2

307.7

1071

2721

R01AD12

ATC

fluticasone furoate; nasal

2.9

307.7

5119

26238

R06AE09

ATC

levocetirizine; oral

4.8

307.7

3296

9291

R01AD11

ATC

triamcinolone; nasal

3.5

307.7

1277

3944

S01GX01

ATC

cromoglicic acid; ophthalmic

7.3

307.7

5389

13725

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.9

307.7

1011

1832

L20.0

ICD-10 Finland

Besnier prurigo

4.3

307.7

2290

6365

Z51.6

ICD-10 Finland

Desensitization to allergens

245.6

307.7

2054

104

S01GX02

ATC

levocabastine; ophthalmic

4.9

307.7

1294

2907

XG474

NOMESCO Finland

Exhalation nntrogen oxide

9.5

307.7

806

904

R96

ICPC

Asthma

4.2

307.7

1636

4392

R06AX26

ATC

fexofenadine; oral

4.5

307.7

1488

3681

R01AD58

ATC

fluticasone, combinations; nasal

3.3

307.7

4645

20763

C01CA24

ATC

epinephrine; parenteral

10.6

307.7

2737

3385

WQ000

NOMESCO Finland

Hyposensibilisation

219.9

307.7

893

V01AA05

ATC

tree pollen; parenteral

33.4

307.7

770

246

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.7

307.7

886

2007

R06AX22

ATC

ebastine; oral

4.2

307.7

3276

10202

R03AC02

ATC

salbutamol; inhalant

5.7

307.7

8047

42425

S01GX08

ATC

ketotifen; ophthalmic

4.9

307.7

1149

2543

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

4.7

307.7

1025

2332

J30.19

ICD-10 Finland

Pollen allergy UNS

6.6

307.7

1796

3187

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

7.3

307.7

503

707

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.8

307.7

1948

5901

V01AA02

ATC

grass pollen; parenteral

79.9

307.7

493

SPAT1267

SPAT

Desensitisation

244.9

307.7

266

R03BA01

ATC

beclometasone; inhalant

3.3

307.7

1750

6022

J45

ICD-10 Finland

Asthma

4.5

307.7

2089

5452

R01AD08

ATC

fluticasone; nasal

4.0

307.7

4830

18977

J30.3

ICD-10 Finland

Other allergic rhinitis

11.0

307.7

1607

1688

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

526.7

307.7

9278

2855

J31.0

ICD-10 Finland

Chronic rhinitis

3.1

299.0

1415

4952

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

288.1

2006

8614

XQ802

NOMESCO Finland

Epicutan test

4.3

286.7

804

1988

R03AK08

ATC

formoterol and beclometasone; inhalant

4.6

284.7

721

1647

R06.2

ICD-10 Finland

Wheezing

4.1

276.6

821

2116

R03BB04

ATC

tiotropium bromide; inhalant

4.0

267.7

829

2202

D07AA02

ATC

hydrocortisone; topical

2.5

265.9

2167

9987

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.2

265.4

1199

4069

R06.0

ICD-10 Finland

Dyspnoea

2.3

262.3

2589

12971

E000001, ,

ATC

2.3

261.0

2609

13137

J45.1

ICD-10 Finland

Nonallergic asthma

3.3

251.5

1030

3290

R03AC12

ATC

salmeterol; inhalant

5.3

245.7

510

983

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

99.1

245.6

129

R03AC13

ATC

formoterol; inhalant

4.6

244.4

616

1399

H02AB04

ATC

methylprednisolone; systemic

2.7

244.0

1512

6086

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.4

243.2

966

3025

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

4.5

239.8

609

1391

R06AX12

ATC

terfenadine; oral

4.0

239.1

718

1862

D11AH01

ATC

tacrolimus; topical

7.9

234.4

329

425

R01AC02

ATC

levocabastine; nasal

4.7

230.2

551

1199

S01GX09

ATC

olopatadine; ophthalmic

4.6

229.7

577

1306

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.3

226.8

613

1469

H02AB07

ATC

prednisone; oral

2.8

224.8

1311

5102

J30.0

ICD-10 Finland

Vasomotor rhinitis

5.2

224.7

481

952

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

219.8

3549

21242

E000002, ,

ATC

2.5

219.6

1631

7143

D07AB08

ATC

desonide; topical

2.6

205.7

1410

5932

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.3

199.5

801

2516

J01FA10

ATC

azithromycin; systemic

2.0

197.0

6837

52055

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.4

196.6

1518

6743

J46

ICD-10 Finland

Status asthmaticus

5.0

194.7

431

877

R03BC01

ATC

cromoglicic acid; inhalant

5.6

169.0

326

586

J01FA09

ATC

clarithromycin; systemic

1.9

168.1

3355

21119

D07AC13

ATC

mometasone; topical

1.9

167.1

2790

16578

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

165.8

3054

18725

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.1

164.9

294

490

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.9

162.4

500

1314

DHB50

NOMESCO Finland

Turbinoplasty

4.2

160.4

444

1080

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

6.6

159.4

260

396

R05

ICD-10 Finland

Cough

1.9

155.4

2352

13473

J34.2

ICD-10 Finland

Deviated nasal septum

3.2

154.9

666

2173

R03DA04

ATC

theophylline; systemic, rectal

4.2

153.1

418

1006

L20

ICD-10 Finland

Atopic dermatitis

3.0

151.6

715

2461

S01GX04

ATC

nedocromil; ophthalmic

5.7

151.2

289

515

R06AX18

ATC

acrivastine; oral

4.7

149.5

360

785

J33.8

ICD-10 Finland

Other polyp of sinus

5.9

148.6

272

465

Z3231

NOMESCO Finland

Registered nurse

1.9

143.9

2633

15978

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

141.1

453

1225

D11AH02

ATC

pimecrolimus; topical

9.6

140.9

167

174

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

7.0

139.5

216

311

D07AC01

ATC

betamethasone; topical

1.7

136.5

3342

22042

R01AD59

ATC

mometasone, combinations; nasal

2.3

135.7

1118

5059

XQ899

NOMESCO Finland

Other assessment of skin

12.9

135.1

131

101

J01FA06

ATC

roxithromycin; oral

1.7

133.5

3392

22574

R02

ICPC

Shortness of breath/dyspnoea

2.2

133.0

1317

6427

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

132.4

1498

7694

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.3

131.9

516

1587

J01AA02

ATC

doxycycline; systemic

1.7

131.7

6649

53039

D02AX

ATC

Other emollients and protectives

3.2

131.6

539

1705

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

131.4

6810

54697

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

131.1

5770

44345

R06AX11

ATC

astemizole; oral

3.4

130.5

502

1528

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.0

124.6

362

911

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

122.4

571

1948

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

117.4

1948

11364

R03BC03

ATC

nedocromil; inhalant

2.8

116.1

629

2327

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.0

114.3

522

1759

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

111.8

3452

23919

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

7.0

109.7

168

239

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

109.4

2163

13269

A02BC05

ATC

esomeprazole; systemic

1.6

109.2

3309

22788

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.7

106.8

348

949

E000007, ,

ATC

2.5

103.1

707

2934

D02AE01

ATC

carbamide; topical

2.5

100.6

693

2882

A02BC02

ATC

pantoprazole; systemic

1.6

95.6

5537

43906

E000006, ,

ATC

2.5

95.5

664

2771

R03AK11

ATC

formoterol and fluticasone; inhalant

3.8

94.8

297

788

N05BB01

ATC

hydroxyzine; systemic

2.4

94.5

691

2950

395

Kela drug reimbursment

Dupilumab

12.3

94.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

93.7

3089

21531

UDM02

NOMESCO Finland

Sinoscopy

3.9

92.5

281

730

D11AH05

ATC

dupilumab; topical

11.4

92.3

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

92.2

2917

20115

L50.0

ICD-10 Finland

Allergic urticaria

3.1

91.6

409

1358

R03CC02

ATC

salbutamol; systemic

1.9

91.3

1335

7425

S01GX06

ATC

emedastine; ophthalmic

5.1

90.1

190

370

R03DC01

ATC

zafirlukast; oral

6.1

90.0

157

256

J20

ICD-10 Finland

Acute bronchitis

2.0

89.3

1109

5835

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.8

88.8

165

286

E000003, ,

ATC

2.7

88.4

508

1933

XG405

NOMESCO Finland

Education on PEF monitoring

5.0

87.7

193

390

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

87.2

2086

13378

J33.0

ICD-10 Finland

Polyp of nasal cavity

3.6

85.7

294

830

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.7

83.6

276

759

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

3.2

81.8

334

1052

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

81.5

930

4741

D11AX14

ATC

[U] tacrolimus

7.6

81.0

116

153

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.0

81.0

379

1292

M25.5

ICD-10 Finland

Pain in joint

1.5

80.2

3229

23367

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

5.0

78.3

172

347

XG430

NOMESCO Finland

Spiroegometry

8.1

77.5

104

127

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

6.5

77.2

127

195

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.0

76.3

167

336

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

76.0

3831

28975

L50.8

ICD-10 Finland

Other urticaria

3.4

76.0

274

799

SPAT1058

SPAT

PEF monitoring instruction

2.2

75.1

695

3270

G47.3

ICD-10 Finland

Sleep apnoea

1.7

74.1

1744

11080

S01GX05

ATC

lodoxamide; ophthalmic

4.7

73.7

174

373

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

10.6

73.6

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

4.3

73.5

193

450

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

73.3

1819

11713

M79.6

ICD-10 Finland

Pain in limb

1.5

72.6

4042

31099

J01DA01

ATC

[U] cefalexin

1.4

67.1

5367

43983

J02AC01

ATC

fluconazole; systemic

1.5

67.0

3753

28772

J37.0

ICD-10 Finland

Chronic laryngitis

3.0

66.5

309

1049

N02AX02

ATC

tramadol; systemic, rectal

1.5

65.7

3069

22684

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

65.6

2220

15332

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

4.6

65.0

156

339

WQ000, ,

SPAT

137.0

64.6

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

64.0

2118

14546

XQ801

NOMESCO Finland

Intracutantest

6.7

63.8

102

152

J01DB01

ATC

cefalexin; oral

1.6

63.8

7936

70508

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

4.4

63.6

162

369

R74

ICPC

Upper respiratory infection acute

1.4

63.3

4428

35261

J30.2

ICD-10 Finland

Other seasonal allergic rhinitis

7.0

62.6

137

M01AE02

ATC

naproxen; oral, rectal

1.4

62.3

5627

46855

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

62.0

1058

6127

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

61.9

488

2147

XQ820

NOMESCO Finland

Exposure to medicinal substance

6.9

61.7

139

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

61.3

2943

21805

M03BX02

ATC

tizanidine; oral

1.4

61.0

5477

45478

A02BC01

ATC

omeprazole; systemic

1.6

60.9

2013

13799

R05

ICPC

Cough

1.5

60.5

2500

17966

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.3

60.4

233

709

R51.80

ICD-10 Finland

Headache

1.6

60.2

1861

12564

R01AC07

ATC

nedocromil; nasal

7.2

60.1

122

R03BB01

ATC

ipratropium bromide; inhalant

3.8

59.4

187

498

R06AE08, ,

ATC

4.9

59.3

130

262

M79.1

ICD-10 Finland

Myalgia

1.6

59.3

1575

10256

XQ830

NOMESCO Finland

Exposure to foodstuff

10.4

59.3

J32.4

ICD-10 Finland

Chronic pansinusitis

3.6

58.9

194

533

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

58.7

3008

22529

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.5

58.2

142

313

ZXC60

NOMESCO Finland

Application of heat

3.9

57.5

170

433

D11AX15

ATC

[U] pimecrolimus

8.5

57.4

J01CA04

ATC

amoxicillin; systemic

1.6

57.2

8510

77306

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

57.1

1043

6152

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

56.4

364

1463

J01FA15

ATC

telithromycin; oral

1.9

56.2

791

4311

A02BC04

ATC

rabeprazole; oral

1.9

56.0

766

4137

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

56.0

1795

12195

G44.2

ICD-10 Finland

Tension-type headache

1.6

55.7

1448

9368

R01AC03

ATC

azelastine; nasal

8.0

55.2

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

54.7

1369

8771

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.1

54.5

155

D07AD01

ATC

clobetasol; topical

1.6

53.6

1298

8244

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

52.9

512

2445

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

52.8

1766

12089

J01DA06

ATC

[U] cefuroxime

1.7

52.5

1163

7220

ZX101

NOMESCO Finland

Sublingual

113.0

52.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

52.4

677

3586

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

52.1

1912

13348

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

51.0

899

5243

J01FF01

ATC

clindamycin; systemic

1.5

50.9

2110

15091

R53

ICD-10 Finland

Malaise and fatigue

1.5

50.1

2384

17504

J01

ICD-10 Finland

Acute sinusitis

1.9

49.9

693

3758

M01AH05

ATC

etoricoxib; oral

1.4

49.7

5258

44173

A02BC03

ATC

lansoprazole; oral

1.5

49.3

1748

12098

S87

ICPC

Dermatitis/atopic eczema

2.3

48.8

365

1568

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

8.4

48.5

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

48.2

1148

7249

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.6

48.2

115

249

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

48.1

1611

11008

A07AA02

ATC

nystatin; oral

2.3

47.7

372

1628

X58

ICD-10 Finland

Exposure to other specified factors

1.5

47.2

1536

10428

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.3

47.0

177

531

49300

ICD-8 Finland

Asthma, bronchiale

3.5

46.6

165

476

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.9

46.3

135

341

R06.5

ICD-10 Finland

Mouth breathing

1.8

46.1

791

4572

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

45.4

786

4555

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

44.9

1258

8253

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

43.7

2285

17001

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

4.6

43.6

105

229

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

43.5

828

4924

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

43.5

3038

23737

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

43.3

3716

29986

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

43.0

3354

26654

SPAT1057

SPAT

Peak expiratory flow measurement

2.9

42.8

210

735

R42

ICD-10 Finland

Dizziness and giddiness

1.5

42.8

1583

11018

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

42.8

2126

15661

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.7

42.8

233

862

L01

ICPC

Neck symptom/complaint

1.5

42.7

1619

11323

J01DC02

ATC

cefuroxime; systemic

1.9

42.0

519

2706

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

41.7

1593

11155

Z58.8

ICD-10 Finland

Other problems related to physical environment

10.9

40.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

40.6

2647

20401

N03AX16

ATC

[U] pregabalin

1.5

40.6

1494

10378

N06AX11

ATC

mirtazapine; oral

1.4

40.4

2815

21923

R01AD

ATC

Corticosteroids

4.3

40.1

103

237

Z01.2

ICD-10 Finland

Dental examination

1.3

40.0

5059

43031

Z3226

NOMESCO Finland

Physiotherapist

1.5

39.5

1369

9390

K07.60

ICD-10 Finland

Snapping jaw

1.8

39.5

631

3568

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

39.5

879

5445

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

39.3

698

4068

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

39.3

1681

12020

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

39.2

182

618

A02BA02

ATC

ranitidine; systemic

1.6

39.1

982

6264

L20.8

ICD-10 Finland

Other atopic dermatitis

3.1

39.0

167

542

J01DA09

ATC

[U] cefadroxil

1.4

38.8

2195

16499

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

4.8

38.8

183

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.9

38.7

113

286

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

6.1

38.6

109

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

38.4

1494

10483

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

37.9

2038

15177

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

37.8

1185

7948

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

37.8

573

3187

J01MA12

ATC

levofloxacin; systemic

1.6

37.6

1056

6913

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.6

37.5

122

333

ZXA10

NOMESCO Finland

Bilateral

1.5

37.5

1205

8126

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

37.2

576

3226

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

37.0

427

2174

E000004, ,

ATC

2.6

36.7

214

820

R49.08

ICD-10 Finland

Other specified dysphonia

2.7

36.3

195

717

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

8.2

36.1

S01BA01

ATC

dexamethasone; ophthalmic

2.5

36.1

240

979

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

36.1

384

1899

M79.7

ICD-10 Finland

Fibromyalgia

2.1

35.8

354

1704

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

8.9

35.3

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

4.7

35.1

171

J05AB01

ATC

aciclovir; systemic

1.4

34.7

1762

12968

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

34.7

950

6179

L03

ICPC

Low back symptom/complaint

1.3

34.5

2690

21210

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

34.5

787

4899

505

Kela drug reimbursment

Allergy to cow's milk in infants

6.2

34.4

J04.0

ICD-10 Finland

Acute laryngitis

1.8

34.3

545

3073

J01MA14

ATC

moxifloxacin; systemic

1.8

34.3

567

3236

M54.5

ICD-10 Finland

Low back pain

1.3

34.2

3274

26588

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

34.2

302

1392

K30

ICD-10 Finland

Functional dyspepsia

1.6

34.1

966

6331

Z71.8

ICD-10 Finland

Other specified counselling

1.3

34.0

3437

28113

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

6.1

34.0

H10

ICD-10 Finland

Conjunctivitis

1.6

33.8

890

5733

R29

ICPC

Respiratory symptom/complaint other

1.7

33.7

626

3691

GD1AA, ,

SPAT

1.4

33.6

1676

12288

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

33.6

2265

17458

J01FA01

ATC

erythromycin; systemic

1.4

33.5

1430

10190

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

33.3

1014

6748

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

3.9

33.3

250

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

33.2

785

4928

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.7

33.2

104

277

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

33.0

1968

14867

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

32.8

1132

7738

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

32.7

1056

7119

M02AA07

ATC

piroxicam; topical

1.4

32.4

2001

15198

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

4.1

32.3

212

N02BE01

ATC

paracetamol; systemic, rectal

1.4

32.2

7883

72381

WX002

NOMESCO Finland

Sedation and analgesia

1.5

32.1

1150

7915

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

32.1

826

5291

R09

ICPC

Sinus symptom/complaint

1.6

32.1

920

6041

R03BA07

ATC

mometasone; inhalant

3.8

31.8

258

J05AB11

ATC

valaciclovir; oral

1.5

31.7

1146

7901

R12

ICD-10 Finland

Heartburn

1.6

31.7

765

4825

T78.3

ICD-10 Finland

Angioneurotic oedema

3.1

31.7

133

427

DM1QA, ,

SPAT

1.7

31.6

543

3133

WZC30

NOMESCO Finland

Teaching

1.5

31.5

1085

7410

D07CB01

ATC

triamcinolone and antibiotics; topical

2.9

31.4

150

518

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.5

31.0

108

309

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

31.0

844

5478

C09CA06

ATC

candesartan; oral

1.4

30.9

1633

12073

R01AX03

ATC

ipratropium bromide; nasal

3.1

30.9

128

408

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

30.7

933

6203

Z2221

NOMESCO Finland

Medical doctor

1.3

30.5

2233

17384

J01AA04

ATC

lymecycline; systemic

1.4

30.5

1398

10083

R51

ICD-10 Finland

Headache

1.6

30.4

669

4125

R75

ICPC

Sinusitis acute/chronic

1.8

30.3

506

2894

R21

ICPC

Throat symptom/complaint

1.3

30.3

2942

23844

L17

ICPC

Foot/toe symptom/complaint

1.3

30.1

2525

20045

M54

ICD-10 Finland

Dorsalgia

1.5

30.1

1226

8648

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

30.1

972

6547

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

30.1

487

2762

D09AB01

ATC

zinc bandage without supplements; topical

2.9

30.1

139

472

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

3.3

30.0

111

330

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

30.0

818

5308

A06AC51

ATC

ispaghula, combinations; oral

2.0

29.9

330

1653

J02AC02

ATC

itraconazole; systemic

1.4

29.5

1223

8652

344

Kela drug reimbursment

Omalizumab

7.1

29.5

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

29.5

352

1813

L50.3

ICD-10 Finland

Dermatographic urticaria

2.4

29.4

210

885

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

29.4

706

4446

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

29.4

1210

8552

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

29.1

1491

10957

R07

ICPC

Sneezing/nasal congestion

1.5

29.0

844

5556

F29

ICPC

Eye symptom/complaint other

1.5

28.8

960

6507

EMB10

NOMESCO Finland

Tonsillectomy

1.6

28.7

789

5126

S29

ICPC

Skin symptom/complaint other

1.4

28.7

1671

12537

R83

ICPC

Respiratory infection other

1.3

28.6

3226

26617

SPAT1059

SPAT

Spirometry at the office

2.0

28.4

310

1548

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

28.4

236

1062

N03AX12

ATC

[U] gabapentin; oral

1.5

28.4

1025

7059

SPAT1325

SPAT

Vaccination

1.3

28.4

2451

19510

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

28.3

789

5142

L13

ICPC

Hip symptom/complaint

1.5

28.1

1147

8089

XG432

NOMESCO Finland

Cold exponation and spirometry

7.5

27.9

R00.2

ICD-10 Finland

Palpitations

1.6

27.6

755

4901

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

27.5

176

706

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

27.4

588

3600

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

27.2

3970

33752

J01MA02

ATC

ciprofloxacin; systemic

1.3

26.9

2424

19381

R4110

NOMESCO Finland

Physiotherapy

1.3

26.9

1933

14968

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.4

26.9

194

822

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

26.8

770

5051

H01

ICPC

Ear pain/earache

1.4

26.8

1393

10248

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

26.8

1831

14073

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

26.7

1734

13222

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

26.6

1840

14163

N06AX21

ATC

duloxetine; oral

1.5

26.6

977

6748

N05BA04

ATC

oxazepam; oral

1.3

26.4

2029

15862

A04

ICPC

Weakness/tiredness general

1.4

26.3

1499

11192

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.2

26.1

105

329

X57

ICD-10 Finland

Unspecified privation

2.4

26.1

188

797

A01AB09

ATC

miconazole; local oral

1.6

25.8

563

3462

L15

ICPC

Knee symptom/complaint

1.3

25.8

1994

15594

M01AB05

ATC

diclofenac; systemic, rectal

1.3

25.7

5112

44935

SPAT1310

SPAT

Counselling related to known health issue

1.3

25.6

2709

22092

H92.0

ICD-10 Finland

Otalgia

1.6

25.6

719

4693

UJF32

NOMESCO Finland

Coloscopy

1.4

25.6

1443

10756

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.3

25.4

199

874

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

25.2

1832

14191

L12

ICPC

Hand/finger symptom/complaint

1.4

25.1

1641

12512

W84

ICD-10 Finland

Unspecified threat to breathing

5.3

25.1

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

25.0

3619

30644

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

5.4

25.0

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

24.9

3371

28312

N01

ICPC

Headache

1.3

24.9

1640

12520

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

24.7

800

5383

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.7

24.7

135

502

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.4

24.7

164

670

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.5

24.6

247

R03DX05

ATC

omalizumab; parenteral

6.8

24.5

G43.3

ICD-10 Finland

Complicated migraine

2.1

24.4

236

1128

A03FA02

ATC

cisapride; oral, rectal

1.8

24.4

403

2299

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.9

24.3

298

1549

R04

ICPC

Breathing problem other

1.9

24.3

299

1557

Z01.7

ICD-10 Finland

Laboratory examination

1.4

24.1

1407

10538

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

24.0

856

5871

M01AH01

ATC

celecoxib; oral

1.4

23.8

961

6752

D06AX01

ATC

fusidic acid; topical

1.5

23.7

786

5314

N02BF02

ATC

pregabalin; oral

1.6

23.5

520

3207

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

23.5

2625

21511

J01MA06

ATC

norfloxacin; oral

1.5

23.3

748

5023

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.1

23.3

227

1089

E0001A1, ,

ATC

2.0

23.2

262

1324

A12

ICPC

ALLERGY/ALLERGIC REACTION

4.2

23.1

144

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.7

23.0

434

2569

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

22.9

2673

22007

S01AA01

ATC

chloramphenicol; ophthalmic

1.7

22.8

398

2305

G43

ICD-10 Finland

Migraine

1.5

22.8

764

5173

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.1

22.8

210

985

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

22.8

1410

10647

D06BX01

ATC

metronidazole; topical

1.5

22.8

791

5396

ZXE00

NOMESCO Finland

One hour or less

1.3

22.6

3066

25682

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

2.5

22.6

147

595

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

22.6

317

1722

J31.1

ICD-10 Finland

Chronic nasopharyngitis

3.0

22.6

327

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

22.5

777

5294

C07AA05

ATC

propranolol; systemic

1.3

22.5

1819

14279

OAA65, ,

SPAT

1.3

22.5

2414

19666

D82

ICPC

Teeth/gum disease

1.2

22.4

3933

33902

WX722

NOMESCO Finland

PEEP

2.0

22.3

241

1201

R03BB07

ATC

umeclidinium bromide; inhalant

4.1

22.1

149

N05CF02

ATC

zolpidem; oral

1.4

22.0

1248

9294

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

21.9

1686

13137

J32

ICD-10 Finland

Chronic sinusitis

2.9

21.9

100

338

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

21.9

2010

16040

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

21.9

1064

7724

EMB30

NOMESCO Finland

Adenotomy

1.6

21.8

562

3597

J47

ICD-10 Finland

Bronchiectasis

3.2

21.7

263

F71

ICPC

Conjunctivitis allergic

4.6

21.6

110

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

21.6

1471

11262

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

21.6

704

4741

R07.0

ICD-10 Finland

Pain in throat

1.4

21.6

852

5958

L16

ICPC

Ankle symptom/complaint

1.4

21.6

1167

8623

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

21.5

1347

10185

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

21.5

1588

12302

D01

ICPC

Abdominal pain/cramps general

1.4

21.4

1343

10153

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

21.3

193

900

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

21.3

495

3090

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

21.2

182

831

N05CF01

ATC

zopiclone; oral

1.3

21.2

1873

14870

R01BA01

ATC

phenylpropanolamine; oral

1.8

21.1

351

2006

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.7

21.1

109

394

WW200, ,

SPAT

1.3

21.1

2056

16525

R01AD04

ATC

flunisolide; nasal

4.2

21.1

133

R13

ICD-10 Finland

Dysphagia

1.7

21.0

404

2403

K08.80

ICD-10 Finland

Toothache NOS

1.4

21.0

894

6336

L08

ICPC

Shoulder symptom/complaint

1.3

21.0

1608

12519

B37.0

ICD-10 Finland

Candidal stomatitis

2.8

20.9

103

363

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

20.9

957

6870

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.8

20.9

164

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.6

20.9

452

2773

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

20.9

517

3277

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

20.9

329

1852

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

20.8

412

2470

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

20.8

569

3691

UDC00

NOMESCO Finland

Ear microscopy

1.6

20.8

563

3644

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

20.7

751

5164

J33.9

ICD-10 Finland

Nasal polyp, unspecified

2.8

20.7

103

365

M03AX01

ATC

botulinum toxin; parenteral

2.2

20.7

181

833

A01

ICPC

Pain general/multiple sites

1.5

20.7

725

4953

R06AX25

ATC

mizolastine; oral

4.9

20.6

A97

ICPC

No disease

1.3

20.6

1783

14110

D07XB05

ATC

dexamethasone; topical

2.1

20.5

184

855

J01AA07

ATC

tetracycline; systemic

1.3

20.5

1347

10250

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

20.5

373

2187

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.7

20.5

111

412

N02CC04

ATC

rizatriptan; oral

1.6

20.4

559

3627

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

20.4

541

3485

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

3.9

20.3

150

N06AB04

ATC

citalopram; systemic

1.3

20.2

1419

10905

N06BA04

ATC

methylphenidate; oral

1.5

20.2

619

4115

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

20.2

770

5349

D07AB01

ATC

clobetasone; topical

2.0

20.1

222

1115

N06AB10

ATC

escitalopram; oral

1.3

20.1

2137

17349

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

6.4

20.0

S18

ICPC

Laceration/cut

1.2

20.0

3340

28532

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

20.0

749

5185

S01AD03

ATC

aciclovir; ophthalmic

2.0

19.9

221

1112

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

3.6

19.9

184

N06AX12

ATC

bupropion; oral

1.4

19.8

872

6216

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.4

19.8

110

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

19.8

566

3706

H02

ICPC

Hearing complaint

1.5

19.8

670

4545

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

19.8

397

2389

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

19.7

663

4492

L02

ICPC

Back symptom/complaint

1.4

19.7

1031

7571

AA40B, ,

NOMESCO Finland

5.3

19.5

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

19.5

872

6236

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

19.4

632

4252

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

19.4

934

6760

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

19.4

3556

30640

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

8.0

19.3

OAB93, ,

SPAT

1.4

19.3

815

5769

M02AA10

ATC

ketoprofen; topical

1.4

19.3

895

6441

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

19.2

371

2210

S88

ICPC

Dermatitis contact/allergic

2.0

19.2

205

1017

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

19.2

2599

21679

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

19.1

7306

67722

DPA30

NOMESCO Finland

Sphenotomy

3.6

19.1

175

K07.61

ICD-10 Finland

Cracking jaw joint

1.9

19.0

254

1360

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

18.9

4250

37345

R52.2

ICD-10 Finland

Other chronic pain

1.8

18.8

282

1566

N89

ICPC

Migraine

1.5

18.7

546

3590

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

18.5

1024

7585

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

18.4

2700

22707

XG488

NOMESCO Finland

Other provokation of respiratroy tract

7.6

18.3

DHB40

NOMESCO Finland

Conchotomy

7.2

18.3

N02BF01

ATC

gabapentin; oral

1.5

18.3

694

4815

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

18.2

561

3733

C07AB07

ATC

bisoprolol; oral

1.3

18.2

2254

18602

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

18.1

397

2446

J33

ICD-10 Finland

Nasal polyp

3.2

18.0

216

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.1

17.9

119

M01AX17

ATC

nimesulide; oral

1.4

17.9

1062

7950

ZX112

NOMESCO Finland

Subcutaneous

2.2

17.8

141

624

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

17.7

184

905

J01DA08

ATC

[U] cefaclor

1.3

17.7

1421

11112

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

17.6

1019

7599

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.5

17.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

17.3

4042

35541

R52.9

ICD-10 Finland

Pain, unspecified

1.4

17.3

807

5807

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.3

17.3

127

545

N06AB06

ATC

sertraline; oral

1.3

17.2

1128

8573

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

17.1

366

2239

XG431

NOMESCO Finland

Oscillometric spirometry with exercise provocation

4.6

17.1

A99

ICPC

Disease/condition unspecnature/site

1.4

17.0

745

5302

R49.01

ICD-10 Finland

Functional dysphonia

1.9

17.0

206

1069

50708

ICD-8 Finland

Hay fever, Alia definita

5.0

17.0

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

17.0

932

6890

A98

ICPC

Health maint/preventive medicine

2.0

17.0

9706

94175

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

16.9

407

2563

J35.1

ICD-10 Finland

Hypertrophy of tonsils

1.7

16.9

279

1593

H01.0

ICD-10 Finland

Blepharitis

1.4

16.9

651

4527

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.7

16.9

315

F03

ICPC

Eye discharge

1.4

16.9

653

4545

SPAT1283

SPAT

Restricted health certificate

1.2

16.9

2343

19550

D11

ICPC

Diarrhoea

1.3

16.9

1264

9785

OAB42, ,

SPAT

1.3

16.9

1250

9662

N06AX26

ATC

vortioxetine; oral

1.4

16.8

833

6057

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

16.8

509

3377

M35.7

ICD-10 Finland

Hypermobility syndrome

2.0

16.7

177

877

P06

ICPC

Sleep disturbance

1.3

16.7

1228

9482

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

16.6

551

3721

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

16.6

528

3537

D19

ICPC

Teeth/gum symptom/complaint

1.2

16.6

3085

26517

ZXD20

NOMESCO Finland

Day surgery

1.4

16.6

854

6250

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

16.6

533

3579

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

16.5

300

1760

C05AA08

ATC

fluocortolone; rectal, topical

1.4

16.5

733

5231

WIX00

NOMESCO Finland

Allergy cleanup guidance

6.0

16.5

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

16.4

7206

67045

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

16.3

958

7157

XG405, ,

SPAT

2.4

16.3

106

431

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

16.3

110

455

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

16.2

917

6810

SPAT1324

SPAT

Screening procedure

0.8

16.2

1025

13007

R50.9

ICD-10 Finland

Fever, unspecified

1.3

16.2

1259

9792

4222

FHL

Endonasal etmoidectomy

4.3

16.2

A02BA04

ATC

nizatidine; systemic

1.7

16.2

290

1695

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.2

16.2

190

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

16.2

499

3322

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

16.2

2719

23126

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

16.1

1417

11199

N05BA12

ATC

alprazolam; oral

1.5

16.1

608

4211

XQ817, ,

NOMESCO Finland

11.9

16.1

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

16.1

400

2540

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

16.0

597

4126

SPAT1312

SPAT

General health counselling

1.2

16.0

2981

25609

A03

ICPC

Fever

1.2

16.0

2035

16809

F32

ICD-10 Finland

Depressive episode

1.5

16.0

600

4154

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

1.8

16.0

259

1473

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

3.6

15.9

139

OAB44, ,

SPAT

1.3

15.9

1183

9143

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

15.9

641

4496

R07.3

ICD-10 Finland

Other chest pain

1.4

15.9

668

4721

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

15.8

703

5017

TQC05

NOMESCO Finland

Puncture of skin of upper limb

6.7

15.8

R35

ICD-10 Finland

Polyuria

1.6

15.8

333

2033

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

15.7

518

3496

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

15.7

1461

11631

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

15.6

1511

12082

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

15.6

5742

52397

N06AA09

ATC

amitriptyline; systemic

1.5

15.6

437

2849

H29

ICPC

Ear symptom/complaint other

1.4

15.6

830

6104

C08DA01

ATC

verapamil; systemic

1.9

15.6

189

982

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

2.9

15.6

241

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

15.5

672

4774

L50.2

ICD-10 Finland

Urticaria due to cold and heat

3.7

15.5

128

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

15.5

138

642

R06

ICD-10 Finland

Abnormalities of breathing

2.5

15.5

394

SPAT1211

SPAT

Application of soft bandage

1.4

15.4

665

4720

N02CC07

ATC

frovatriptan; oral

1.5

15.4

432

2819

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

15.3

449

2956

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

2.0

15.3

167

838

N06AX16

ATC

venlafaxine; oral

1.3

15.2

1274

10004

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

15.2

243

1377

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

15.1

191

1006

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

15.1

189

993

H60

ICD-10 Finland

Otitis externa

1.5

15.0

492

3315

M24.2

ICD-10 Finland

Disorder of ligament

2.2

15.0

126

572

GX1C5, ,

SPAT

3.0

15.0

209

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

15.0

1773

14510

R4110, ,

SPAT

1.4

15.0

781

5724

A07DA03

ATC

loperamide; oral

2.1

14.9

138

651

S21

ICPC

Skin texture symptom/complaint

1.3

14.9

1103

8515

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

14.9

510

3467

N39.3

ICD-10 Finland

Stress incontinence

1.5

14.9

426

2791

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.5

14.9

348

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

14.8

373

2375

P01AB01

ATC

metronidazole; oral, rectal

1.2

14.8

3078

26668

F17

ICPC

Glasses symptom/complaint

2.6

14.7

316

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

14.6

2772

23809

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

14.5

732

5334

SBB10

NOMESCO Finland

Dental impressions

1.3

14.5

909

6855

N17

ICPC

Vertigo/dizziness

1.4

14.5

822

6107

N02CC06

ATC

eletriptan; oral

1.6

14.4

372

2382

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

14.4

674

4851

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

14.4

502

3425

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.9

14.4

165

842

A01AB04

ATC

amphotericin B; local oral

1.9

14.4

175

911

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.2

14.4

115

513

S06.0

ICD-10 Finland

Concussion

1.3

14.3

907

6851

D06

ICPC

Abdominal pain localized other

1.4

14.3

821

6110

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

14.3

248

1439

L30

ICD-10 Finland

Other dermatitis

1.8

14.2

229

1300

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

14.2

2121

17782

M54.8

ICD-10 Finland

Other dorsalgia

1.6

14.2

362

2312

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

1.8

14.2

208

1150

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

14.1

548

3817

SPAT1260

SPAT

Consultation of another employee

1.3

14.1

1222

9633

R11

ICD-10 Finland

Nausea and vomiting

1.4

14.1

753

5542

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.6

14.0

324

2023

D06BB03

ATC

aciclovir; topical

1.6

14.0

301

1846

R60.0

ICD-10 Finland

Localized oedema

1.4

13.9

636

4559

WQ007, ,

NOMESCO Finland

6.1

13.9

H93.1

ICD-10 Finland

Tinnitus

1.5

13.9

441

2954

XG466

NOMESCO Finland

Sleep oxymetry

2.0

13.8

146

724

U07

ICPC

Urine symptom/complaint other

1.5

13.8

509

3511

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

13.8

708

5176

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

13.8

645

4645

D01AA02

ATC

natamycin; topical

2.0

13.8

145

719

L04

ICPC

Chest symptom/complaint

1.5

13.7

487

3335

J32.1

ICD-10 Finland

Chronic frontal sinusitis

3.2

13.7

159

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.4

13.7

363

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

13.6

681

4956

D07XC01

ATC

betamethasone; topical

1.4

13.6

686

5000

J32.8

ICD-10 Finland

Other chronic sinusitis

3.4

13.6

140

SDA03

NOMESCO Finland

Periodontal treatment

1.2

13.5

3728

33034

N06BA12

ATC

lisdexamfetamine; oral

1.8

13.5

193

1058

L11

ICPC

Wrist symptom/complaint

1.3

13.5

905

6888

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.0

13.5

149

751

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.8

13.5

201

1116

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

13.5

563

3975

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

13.4

624

4491

J01MA01

ATC

ofloxacin; systemic

1.6

13.4

348

2235

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

13.4

600

4290

R05DA01

ATC

ethylmorphine; oral

1.5

13.3

437

2946

L60.0

ICD-10 Finland

Ingrowing nail

1.5

13.3

406

2697

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.4

13.3

561

3966

SPAT1254

SPAT

Administration of medicine

1.3

13.3

1112

8724

D10AX03

ATC

azelaic acid; topical

1.3

13.3

883

6715

H57.1

ICD-10 Finland

Ocular pain

1.5

13.3

355

2294

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

13.2

523

3655

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.8

13.2

202

1132

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.7

13.1

236

1383

OAA51, ,

SPAT

2.4

13.1

382

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.1

2817

24416

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

13.1

377

2474

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.0

13.1

179

M54.1

ICD-10 Finland

Radiculopathy

1.7

13.0

245

1453

K58

ICD-10 Finland

Irritable bowel syndrome

1.6

13.0

262

1584

DM1AI, ,

SPAT

2.3

12.9

422

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

12.9

797

5996

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.3

12.8

793

5966

L01

ICD-10 Finland

Impetigo

1.8

12.7

188

1042

E66.8

ICD-10 Finland

Other obesity

1.4

12.7

482

3344

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

5.1

12.7

N76.0

ICD-10 Finland

Acute vaginitis

1.3

12.7

826

6262

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

12.7

1319

10623

N06AB03

ATC

fluoxetine; oral

1.3

12.6

906

6960

DM1AA, ,

SPAT

1.8

12.6

171

923

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.5

12.6

335

2163

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.3

12.6

1155

9164

J01DC04

ATC

cefaclor; oral

2.0

12.5

130

642

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.7

12.5

227

1334

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

12.5

3042

26628

M01AH02

ATC

rofecoxib; oral

1.4

12.5

485

3380

R51.81

ICD-10 Finland

Facial pain NOS

1.8

12.5

184

1020

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

12.4

115

544

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

12.4

421

2858

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

12.4

595

4301

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

12.4

712

5296

L28

ICPC

Limited function/disability (L)

1.3

12.4

830

6315

A08

ICPC

Swelling

1.6

12.4

259

1579

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

12.4

655

4812

W19

ICD-10 Finland

Unspecified fall

1.4

12.4

672

4957

SPAT1263

SPAT

Sampling

1.2

12.4

3490

30920

P01

ICPC

Feeling anxious/nervous/tense

1.2

12.4

1892

15876

N03AX09

ATC

lamotrigine; oral

1.4

12.3

501

3519

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.1

12.3

154

L10

ICPC

Elbow symptom/complaint

1.4

12.3

473

3288

R4190

NOMESCO Finland

Nutritional therapy

1.5

12.3

392

2628

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

12.3

148

769

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

12.3

287

1799

R04.0

ICD-10 Finland

Epistaxis

1.5

12.2

339

2208

L86

ICPC

Back syndrome with radiating pain

1.5

12.2

392

2634

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

12.2

361

2385

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

4.1

12.2

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

1.8

12.2

185

1035

K59.0

ICD-10 Finland

Constipation

1.5

12.2

345

2259

R55

ICD-10 Finland

Syncope and collapse

1.4

12.1

564

4056

H03AA01

ATC

levothyroxine sodium; systemic

1.2

12.1

1527

12557

SPAT1104

SPAT

Monitoring of emergency patient

1.5

12.1

355

2341

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

12.1

310

1985

N03AX11

ATC

topiramate; oral

1.7

12.0

234

1401

R78

ICPC

Acute bronchitis/bronchiolitis

2.0

12.0

133

672

N02CC05

ATC

almotriptan; oral

1.5

12.0

376

2515

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

11.9

637

4685

Z05

ICPC

Work problem

1.5

11.9

415

2832

UJD02

NOMESCO Finland

Gastroscopy

1.7

11.9

226

1344

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.3

11.9

380

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

11.9

2431

20947

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

11.9

196

1123

J01EA01

ATC

trimethoprim; systemic

1.2

11.8

1783

14929

N04BC05

ATC

pramipexole; oral

1.5

11.8

344

2265

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

11.8

2430

20946

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

11.8

515

3667

F02

ICPC

Red eye

1.5

11.7

370

2477

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

11.7

293

1866

WX320

NOMESCO Finland

Spinalanesthesy

1.2

11.5

1388

11356

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

1.7

11.5

184

1046

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

11.5

148

788

CS494

NOMESCO Finland

Other visual field testing

2.0

11.4

122

609

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.7

11.4

184

1047

SPAT1229

SPAT

Assessment of need for aid

1.6

11.4

281

1783

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

11.4

715

5392

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

11.3

167

926

N05AH04

ATC

quetiapine; oral

1.2

11.3

1593

13241

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

1.6

11.3

227

1371

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

11.3

221

1326

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

11.3

689

5174

B00.11

ICD-10 Finland

Herpes simplex labialis

1.8

11.3

171

957

J38.4

ICD-10 Finland

Oedema of larynx

3.4

11.2

113

S12

ICPC

Insect bite/sting

1.4

11.2

472

3340

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

11.2

121

608

L23

ICD-10 Finland

Allergic contact dermatitis

2.6

11.1

247

R06.4

ICD-10 Finland

Hyperventilation

1.9

11.1

134

698

M54.2

ICD-10 Finland

Cervicalgia

1.4

11.1

596

4389

SAA04

NOMESCO Finland

Special examination of mouth

1.4

11.1

503

3604

XF402

NOMESCO Finland

ECG with work load test

1.5

11.1

396

2718

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.1

11.1

100

470

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

11.1

121

610

D10AF01

ATC

clindamycin; topical

1.5

11.0

377

2565

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

11.0

377

2569

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.5

10.9

372

2529

K80

ICPC

Cardiac arrhythmia NOS

1.4

10.9

471

3345

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.3

10.9

702

5310

297, ,

Kela drug reimbursment

11.0

10.9

Z00.0

ICD-10 Finland

General medical examination

1.2

10.9

1497

12411

XG413

NOMESCO Finland

Spirometry with oscillometry

3.1

10.9

135

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

10.9

134

703

N06BA09

ATC

atomoxetine; oral

2.4

10.9

309

R03DX09

ATC

mepolizumab; parenteral

9.9

10.9

3028

Kela drug reimbursment

Mepolizumab

9.9

10.9

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.2

10.9

428

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

10.8

1025

8155

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

10.8

508

3660

R49.0

ICD-10 Finland

Dysphonia

1.8

10.8

157

868

S01GA51

ATC

naphazoline, combinations; ophthalmic

5.6

10.8

G50.1

ICD-10 Finland

Atypical facial pain

2.0

10.8

119

602

L71.9

ICD-10 Finland

Rosacea, unspecified

1.7

10.8

193

1133

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

10.7

428

2998

M01AC06

ATC

meloxicam; systemic, rectal

1.2

10.7

2066

17685

SPAT1268

SPAT

Allergy testing

3.4

10.7

107

R03

ICPC

Wheezing

2.2

10.7

361

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.8

10.7

165

929

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

10.7

464

3301

E66

ICD-10 Finland

Obesity

1.4

10.7

496

3570

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

1.7

10.6

188

1099

M75

ICD-10 Finland

Shoulder lesions

1.5

10.6

294

1916

A07EB01

ATC

cromoglicic acid; oral

10.4

10.6

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

3.1

10.6

132

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

2.2

10.6

394

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

10.5

818

6352

L20

ICPC

Joint symptom/complaint NOS

1.5

10.5

280

1811

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

10.5

377

2592

DGW00

NOMESCO Finland

Dilatation of eustachian tube

3.7

10.5

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.4

296

1941

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

10.4

217

1325

AA1AD

NOMESCO Finland

CT of head and brain

1.2

10.4

1367

11279

SPAT1153

SPAT

Removal of sutures

1.2

10.4

1739

14691

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.5

10.4

238

XG404, ,

SPAT

2.9

10.4

160

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

10.4

486

3502

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

10.3

162

916

134

Kela drug reimbursment

General erythroderma

3.8

10.3

H10.8

ICD-10 Finland

Other conjunctivitis

2.1

10.3

457

B02AA02

ATC

tranexamic acid; systemic

1.2

10.3

1122

9074

S80.0

ICD-10 Finland

Contusion of knee

1.3

10.3

659

4984

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.4

10.3

281

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.5

10.2

305

2020

SAB03

NOMESCO Finland

Oral health check

1.3

10.2

798

6199

WZB00, ,

SPAT

1.2

10.2

1272

10435

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.7

10.2

200

N30.2

ICD-10 Finland

Other chronic cystitis

2.7

10.2

200

SPAT1281

SPAT

Other administrative function

1.4

10.2

560

4139

J31.2

ICD-10 Finland

Chronic pharyngitis

2.4

10.2

294

4224

FHL

Endonasal anthrostomy

2.4

10.2

270

A02BX02

ATC

sucralfate; oral

1.8

10.2

139

755

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

10.1

294

1937

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

3.3

10.1

111

N06AA10

ATC

nortriptyline; systemic

1.8

10.1

133

714

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

10.1

450

3216

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.1

10.1

468

L14

ICPC

Leg/thigh symptom/complaint

1.4

10.0

540

3979

L26

ICD-10 Finland

Exfoliative dermatitis

7.3

10.0

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

10.0

238

1500

G90.8

ICD-10 Finland

Other disorders of autonomic nervous system

4.3

10.0

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

10.0

2862

25278

L57.0

ICD-10 Finland

Actinic keratosis

1.5

10.0

271

1759

-1, ,

ICD-10 Finland

1.4

10.0

521

3821

K03.80

ICD-10 Finland

Irradiated enamel

1.4

10.0

488

3542

N02CC02

ATC

naratriptan; oral

1.8

10.0

147

817

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

2.5

9.9

232

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

9.9

778

6049

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

9.9

599

4493

UKC02

NOMESCO Finland

Cystoscopy

1.3

9.9

569

4236

50709

ICD-8 Finland

Hay fever, Unspecified

3.4

9.9

103

M22.4

ICD-10 Finland

Chondromalacia patellae

1.5

9.9

256

1647

XF404

NOMESCO Finland

Ambulatory ECG

1.4

9.8

396

2780

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.2

9.8

118

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.7

9.8

156

886

J11

ICD-10 Finland

Influenza, virus not identified

1.8

9.8

147

821

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

9.8

116

602

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

9.8

4813

44165

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

4.4

9.8

M75.8

ICD-10 Finland

Other shoulder lesions

1.5

9.8

290

1920

ZY010

NOMESCO Finland

Hospital outpatient

1.3

9.8

550

4081

R05CB01

ATC

acetylcysteine; inhalant, oral

2.9

9.8

155

J01DB05

ATC

cefadroxil; oral

1.5

9.8

293

1945

H65.2

ICD-10 Finland

Chronic serous otitis media

1.9

9.7

118

617

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

9.7

811

6353

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

9.7

234

1480

L29.9

ICD-10 Finland

Pruritus, unspecified

1.6

9.7

197

1196

H60.8

ICD-10 Finland

Other otitis externa

1.6

9.7

243

1552

L29

ICPC

Musculoskeletal sympt/complt other

1.3

9.6

605

4565

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

9.6

1190

9757

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

9.6

328

2236

H81.3

ICD-10 Finland

Other peripheral vertigo

1.8

9.5

141

785

S01XA18

ATC

ciclosporin; ophthalmic

2.5

9.5

219

S70.0

ICD-10 Finland

Contusion of hip

1.6

9.5

197

1202

S76

ICPC

Skin infection other

1.5

9.5

319

2166

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

9.5

466

3385

J02AB02

ATC

ketoconazole; oral

1.7

9.5

173

1022

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.4

9.5

371

2593

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.4

9.5

359

2495

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

9.4

6877

64750

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

9.4

2223

19327

U02

ICPC

Urinary frequency/urgency

1.2

9.4

1050

8510

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

9.4

634

4829

WZC00, ,

SPAT

1.2

9.4

1279

10584

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

9.4

1627

13777

L30.8

ICD-10 Finland

Other specified dermatitis

1.6

9.4

207

1283

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

9.3

384

2707

DAX08

NOMESCO Finland

Fitting of hearing aid

1.7

9.3

160

929

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.4

9.3

369

2583

L71.8

ICD-10 Finland

Other rosacea

1.8

9.3

124

668

S82

ICPC

Naevus/mole

1.2

9.3

1130

9241

K90.0

ICD-10 Finland

Coeliac disease

1.6

9.3

211

1316

J06.80

ICD-10 Finland

Continuously repeating infections of a child

3.2

9.3

112

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

1.8

9.3

124

669

ACC51

NOMESCO Finland

Release of median nerve

1.4

9.3

429

3085

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.7

9.3

151

864

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

7.4

9.3

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

2.3

9.3

282

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

9.2

650

4980

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

9.2

720

5592

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.6

9.2

195

1196

N62

ICD-10 Finland

Hypertrophy of breast

1.5

9.2

306

2073

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

9.2

455

3308

G04BD12

ATC

mirabegron; oral

1.4

9.2

432

3117

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

9.2

387

2741

A01AB10

ATC

natamycin; local oral

1.6

9.2

224

1423

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

4.2

9.2

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

9.1

426

3069

N03AE01

ATC

clonazepam; systemic

1.5

9.1

310

2110

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

9.1

212

1331

D84.18

ICD-10 Finland

Other specified defect in the complement system

4.8

9.1

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.7

9.1

152

877

K11.2

ICD-10 Finland

Sialoadenitis

1.6

9.1

221

1402

SPAT1360

SPAT

Extensive global examination

1.4

9.1

377

2663

Z73.0

ICD-10 Finland

Burn-out

1.4

9.1

437

3165

NHE20

NOMESCO Finland

Plastic repair of capsule or ligament of ankle joint with transplant

2.9

9.1

140

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

9.1

2084

18075

R50

ICPC

Respiratory, Medication/prescr/renewal

4.0

9.0

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.0

9.0

434

P03

ICPC

Feeling depressed

1.2

9.0

1276

10600

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

9.0

743

5815

N02CD03

ATC

fremanezumab; systemic

1.9

9.0

111

585

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

9.0

341

2371

H00.00

ICD-10 Finland

Hordeolum

1.4

9.0

393

2802

K20

ICD-10 Finland

Oesophagitis

2.0

9.0

428

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

9.0

632

4844

EB1AA, ,

SPAT

1.4

8.9

482

3555

V01AA11

ATC

animals

9.9

8.9

ZXA05

NOMESCO Finland

Left side

1.2

8.9

1153

9492

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

8.9

1111

9114

N02CD06

ATC

rimegepant; oral

2.1

8.9

377

G44.0

ICD-10 Finland

Cluster headache syndrome

2.0

8.9

484

M77.4

ICD-10 Finland

Metatarsalgia

1.4

8.8

457

3348

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

8.8

269

1792

Z2445

NOMESCO Finland

Psychologist

1.4

8.8

436

3172

R68

ICD-10 Finland

Other general symptoms and signs

2.1

8.8

346

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

8.8

1407

11825

L50.1

ICD-10 Finland

Idiopathic urticaria

2.2

8.8

327

N30

ICD-10 Finland

Cystitis

1.3

8.8

703

5480

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.4

8.8

315

2168

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

8.7

129

720

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

8.7

6345

59545

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

2.8

8.7

149

K03.66

ICD-10 Finland

Tooth plaque

1.3

8.7

664

5147

D02

ICPC

Abdominal pain epigastric

1.3

8.7

486

3607

J05AH02

ATC

oseltamivir; oral

2.4

8.6

236

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

8.6

265

1771

J01.4

ICD-10 Finland

Acute pansinusitis

2.2

8.6

305

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.4

8.5

383

2743

M01AX05

ATC

glucosamine; oral

1.3

8.5

540

4079

E61.1

ICD-10 Finland

Iron deficiency

1.4

8.5

319

2214

J03

ICD-10 Finland

Acute tonsillitis

1.4

8.5

353

2495

G93.3

ICD-10 Finland

Postviral fatigue syndrome

2.4

8.5

238

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.4

8.5

301

2068

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.4

8.5

344

2422

N05BA01

ATC

diazepam; systemic, rectal

1.3

8.5

721

5664

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

8.1

8.5

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

8.1

8.5

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

8.5

287

1955

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

8.4

767

6072

M76.6

ICD-10 Finland

Achilles tendinitis

1.4

8.4

325

2267

A11

ICPC

Chest pain NOS

1.4

8.4

443

3255

A29

ICPC

General symptom/complaint other

1.3

8.4

826

6599

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

2.5

8.4

203

M48.0

ICD-10 Finland

Spinal stenosis

1.4

8.4

375

2684

S01AA13

ATC

fusidic acid; ophthalmic

1.5

8.4

257

1717

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

8.3

715

5621

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

8.3

1952

16941

G54.0

ICD-10 Finland

Brachial plexus disorders

1.5

8.3

216

1392

T83

ICPC

Overweight

1.6

8.3

201

1275

OAB95, ,

SPAT

1.2

8.3

953

7748

Z00.8

ICD-10 Finland

Other general examinations

1.3

8.3

630

4879

J02

ICD-10 Finland

Acute pharyngitis

1.3

8.3

509

3830

G43.8

ICD-10 Finland

Other migraine

1.6

8.3

164

992

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

8.3

624

4829

EB1SA, ,

SPAT

1.3

8.2

461

3420

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

8.2

3239

29174

ZYC02, ,

SPAT

1.3

8.2

532

4031

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.7

8.2

139

807

P76

ICPC

Depressive disorder

1.3

8.1

724

5717

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.9

8.1

2040

22616

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.4

8.1

356

2540

E000008, ,

ATC

3.1

8.1

106

R03DX11

ATC

tezepelumab; systemic

14.3

8.1

N94.1

ICD-10 Finland

Dyspareunia

1.6

8.1

171

1050

C03AA03

ATC

hydrochlorothiazide; oral

1.5

8.1

247

1648

N06AB05

ATC

paroxetine; oral

1.4

8.1

395

2870

NA3BG, ,

SPAT

1.4

8.1

345

2451

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

1.6

8.1

159

960

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

2.6

8.1

172

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

8.1

326

2294

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.6

8.1

183

1144

R03AC19

ATC

olodaterol

4.0

8.1

S02CA02

ATC

flumetasone and antiinfectives; otic

1.5

8.1

280

1917

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.4

8.0

412

3016

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

8.0

259

1747

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.0

417

3059

R25.2

ICD-10 Finland

Cramp and spasm

1.6

8.0

160

969

R52

ICD-10 Finland

Pain, not elsewhere classified

1.8

8.0

106

572

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.0

175

1085

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.6

8.0

173

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

8.0

388

2817

J06.89

ICD-10 Finland

Other acute upper respiratory infections of multiple sites

1.4

8.0

290

2002

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

8.0

552

4222

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

8.0

396

2885

T82

ICPC

Obesity

1.4

8.0

360

2583

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.8

8.0

134

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.5

8.0

229

1510

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

7.9

255

1719

RD210, ,

NOMESCO Finland

1.6

7.9

171

1056

NA1BG, ,

SPAT

1.6

7.9

158

957

Z57.2

ICD-10 Finland

Occupational exposure to dust

4.7

7.9

XF640, ,

NOMESCO Finland

1.9

7.9

449

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.6

7.9

164

1004

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.7

7.9

146

868

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

7.9

238

1585

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.4

7.9

394

2874

R03DA05

ATC

aminophylline; systemic, rectal

3.4

7.9

G03DB08

ATC

dienogest; oral

2.1

7.9

316

D03

ICPC

Heartburn

1.4

7.9

277

1902

F33

ICD-10 Finland

Recurrent depressive disorder

1.5

7.8

264

1797

G47.8

ICD-10 Finland

Other sleep disorders

1.5

7.8

209

1357

R23

ICPC

Voice symptom/complaint

1.6

7.8

180

1130

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

7.8

281

1938

L04AX03

ATC

methotrexate; systemic

1.3

7.8

617

4805

A69.2

ICD-10 Finland

Lyme disease

1.4

7.8

367

2653

R03CC03

ATC

terbutaline; systemic

1.4

7.8

299

2087

S01

ICPC

Pain/tenderness of skin

1.4

7.8

301

2104

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.8

2032

17777

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

7.7

178

1117

RL210, ,

NOMESCO Finland

3.4

7.7

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.2

7.7

900

7328

R5110, ,

SPAT

1.4

7.7

350

2515

G04CA01

ATC

alfuzosin; oral

1.4

7.7

318

2249

R30.0

ICD-10 Finland

Dysuria

1.4

7.7

331

2358

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.5

7.7

233

1555

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

7.7

899

7326

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

7.6

695

5504

3089, ,

Kela drug reimbursment

14.8

7.6

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

2.2

7.6

256

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

7.6

344

2468

L91

ICPC

Osteoarthrosis other

2.0

7.6

373

N06AG02

ATC

moclobemide; oral

1.5

7.6

205

1333

J01CF05

ATC

flucloxacillin; systemic

1.3

7.6

517

3945

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.1

7.6

3141

28344

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.8

7.6

101

547

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.3

7.6

467

3517

NH1BG, ,

SPAT

1.6

7.6

172

1077

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.5

7.6

193

1241

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.2

7.5

251

V01AA03

ATC

house dust mites; parenteral

18.1

7.5

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

7.5

184

1172

B00.10

ICD-10 Finland

Herpes simplex facialis

2.0

7.5

382

D09

ICPC

Nausea

1.3

7.5

556

4294

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.2

7.5

980

8076

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

2.2

7.5

284

C07AB02

ATC

metoprolol; systemic

1.3

7.4

681

5397

F34.1

ICD-10 Finland

Dysthymia

1.4

7.4

303

2137

N06AX05

ATC

trazodone; oral

1.6

7.4

170

1066

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

7.4

541

4168

N07CA01

ATC

betahistine; oral

1.4

7.4

278

1932

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

7.4

720

5747

M01AC01

ATC

piroxicam; systemic, rectal

1.3

7.4

515

3944

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.2

7.4

920

7542

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

7.4

191

1232

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

2.2

7.4

279

G01AF05

ATC

econazole; vaginal

1.3

7.4

466

3522

N30.9

ICD-10 Finland

Cystitis, unspecified

1.3

7.4

434

3247

M15

ICD-10 Finland

Polyarthrosis

1.5

7.4

184

1178

NH3AA, ,

SPAT

1.3

7.3

517

3965

S83

ICD-10 Finland

Dislocation, sprain and strain of joints and ligaments of knee

1.6

7.3

183

1171

D01AC03

ATC

econazole; topical

1.5

7.3

250

1707

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

7.3

447

3362

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.4

7.3

360

2621

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.3

7.3

461

3483

3DX05, ,

NOMESCO Finland

13.2

7.3

S22.3

ICD-10 Finland

Fracture of rib

1.4

7.3

350

2537

M01AB55

ATC

diclofenac, combinations; oral

1.5

7.3

224

1498

K04

ICPC

Palpitations/awareness of heart

1.4

7.3

349

2529

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.3

7.3

474

3596

G04CB01

ATC

finasteride; oral

1.6

7.3

175

1110

K62.6

ICD-10 Finland

Ulcer of anus and rectum

2.0

7.3

373

SCA02

NOMESCO Finland

Preventive oral health care

1.2

7.3

1259

10649

S01BA04

ATC

prednisolone; ophthalmic

1.9

7.2

456

S03

ICPC

Warts

1.6

7.2

177

1128

R81

ICPC

Pneumonia

1.5

7.2

209

1381

WX234

NOMESCO Finland

Paracervical blockade

0.6

7.2

153

2356

L08.0

ICD-10 Finland

Pyoderma

2.0

7.2

374

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

2.3

7.2

237

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.2

7.2

1561

13452

J38.5

ICD-10 Finland

Laryngeal spasm

3.1

7.2

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

3.4

7.2

G01AA10

ATC

clindamycin; vaginal

1.2

7.2

1053

8773

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

3.9

7.2

AA1CG, ,

SPAT

1.9

7.2

423

H65

ICD-10 Finland

Nonsuppurative otitis media

1.7

7.1

111

630

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.2

7.1

270

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

7.1

384

2836

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.8

7.1

101

558

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

4.1

7.1

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

7.1

1189

F73

ICPC

Eye infection/inflammation other

1.5

7.1

178

1141

WX400

NOMESCO Finland

Inhalation anesthesy

1.4

7.1

331

2390

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

1.6

7.1

140

848

M01AX01

ATC

nabumetone; oral

1.6

7.1

155

963

K03.08

ICD-10 Finland

Other wear and tear of the teeth

1.5

7.1

200

1316

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.4

7.1

271

1892

WZA10

NOMESCO Finland

Extensive medical or dental certificate

1.8

7.1

524

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.8

7.0

105

589

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.3

7.0

221

B08.4

ICD-10 Finland

Enteroviral vesicular stomatitis with exanthem

1.9

7.0

454

K03.00

ICD-10 Finland

Approximal wear

1.3

7.0

630

4983

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.0

330

2386

R05CA10

ATC

expectorants - combinations

1.8

7.0

100

554

Z2446

NOMESCO Finland

Social worker

1.3

7.0

548

4263

S06

ICPC

Rash localized

1.4

7.0

354

2590

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.2

7.0

247

S16

ICPC

Bruise/contusion

1.5

7.0

190

1241

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.4

7.0

276

1939

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.9

561

4381

4211

FHL

Transeptal septal resection and reconstruction

2.8

6.9

122

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

6.9

955

7909

XF405

NOMESCO Finland

Symptom ECG

2.3

6.9

198

R19.5

ICD-10 Finland

Other faecal abnormalities

1.8

6.9

549

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

1.5

6.9

183

1188

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.9

6.9

429

R053, ,

ICD-10 Finland

1.4

6.9

266

1860

L07

ICPC

Jaw symptom/complaint

1.6

6.9

144

885

M23

ICD-10 Finland

Internal derangement of knee

1.5

6.9

195

1284

E34.35

ICD-10 Finland

Abnormal growth retardation

2.0

6.9

327

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

6.9

859

7046

A02BA03

ATC

famotidine; systemic

1.7

6.9

112

645

L71

ICD-10 Finland

Rosacea

1.5

6.9

200

1325

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.6

6.9

136

825

M23.8

ICD-10 Finland

Other internal derangements of knee

1.4

6.8

270

1895

EMB20

NOMESCO Finland

Adenotonsillectomy

1.5

6.8

206

1374

ZXA00

NOMESCO Finland

Right side

1.2

6.8

1223

10372

H81

ICPC

Excessive ear wax

1.2

6.8

797

6491

D01BA02

ATC

terbinafine; oral

1.2

6.8

1412

12119

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.4

6.8

318

2296

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

6.8

255

1773

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

1.5

6.8

205

1367

D73

ICPC

Gastroenteritis presumed infection

1.3

6.8

416

3133

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.3

6.8

371

2748

S94

ICPC

Ingrowing nail

1.6

6.8

129

775

G04CA02

ATC

tamsulosin; oral

1.3

6.8

542

4230

F01

ICPC

Eye pain

1.4

6.7

246

1703

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

1.7

6.7

110

634

M23.5

ICD-10 Finland

Chronic instability of knee

2.2

6.7

232

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

9.2

6.7

L50

ICD-10 Finland

Urticaria

1.5

6.7

174

1125

J03.8

ICD-10 Finland

Acute tonsillitis due to other specified organisms

2.2

6.7

226

F41.3

ICD-10 Finland

Other mixed anxiety disorders

1.5

6.7

192

1268

D84.19

ICD-10 Finland

Unspecified defect in the complement system

16.4

6.7

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

1.9

6.7

392

SPAT1043

SPAT

Audiometry

1.3

6.7

411

3097

N06AX22

ATC

agomelatine; oral

1.5

6.7

218

1478

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.2

6.7

739

5987

SAB02

NOMESCO Finland

Oral and dental health check by dental hygienist or dental assistant

1.2

6.7

1067

8961

J01.8

ICD-10 Finland

Other acute sinusitis

2.1

6.7

278

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.3

6.7

414

3124

H53.2

ICD-10 Finland

Diplopia

1.5

6.7

165

1056

F81.0

ICD-10 Finland

Specific reading disorder

2.0

6.6

345

D72.1

ICD-10 Finland

Eosinophilia

2.8

6.6

114

C08CA13

ATC

lercanidipine; oral

1.3

6.6

482

3716

P72

ICPC

Schizophrenia

0.4

6.6

864

Z00.1

ICD-10 Finland

Routine child health examination

1.2

6.6

801

6552

X01

ICPC

Genital pain female

1.7

6.6

103

587

SPAT1322

SPAT

Pre-employment physical examination

1.6

6.6

151

950

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

6.5

1591

13827

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

1.7

6.5

100

566

ZXC95

NOMESCO Finland

Use of surgical navigator

2.0

6.5

347

M79

ICD-10 Finland

Other soft tissue disorders, not elsewhere classified

2.2

6.5

216

A07EA06

ATC

budesonide; oral, local oral

1.4

6.5

269

1904

S83.2

ICD-10 Finland

Tear of meniscus, current

1.3

6.5

432

3289

DMW00

NOMESCO Finland

Intubation of maxillary antrum

3.2

6.5

K07.4

ICD-10 Finland

Malocclusion, unspecified

1.6

6.5

148

929

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

6.5

190

1260

D06BB10

ATC

imiquimod; topical

1.4

6.5

324

2366

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

1.6

6.5

158

1007

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.5

314

2282

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.0

6.5

314

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

6.5

348

2570

U13

ICPC

Bladder symptom/complaint other

1.6

6.5

150

945

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.4

6.5

282

2015

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.4

319

2327

L19

ICPC

Muscle symptom/complaint NOS

1.5

6.4

202

1359

G03DB01

ATC

dydrogesterone; oral

1.2

6.4

943

7854

H65.0

ICD-10 Finland

Acute serous otitis media

1.5

6.4

177

1159

D01AC02

ATC

miconazole; topical

1.4

6.4

329

2412

K60.1

ICD-10 Finland

Chronic anal fissure

1.6

6.4

155

986

D12

ICPC

Constipation

1.5

6.4

185

1223

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

6.4

313

2278

49099

ICD-8 Finland

Bronchitis, unspecified

2.2

6.4

224

N02CX04, ,

ATC

1.8

6.4

440

RF211, ,

NOMESCO Finland

3.4

6.4

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

2.4

6.4

175

L30.3

ICD-10 Finland

Infective dermatitis

1.5

6.4

210

1428

G01AF04

ATC

miconazole; vaginal

1.4

6.4

268

1905

SPAT1389

SPAT

Visit based on need for special support

1.3

6.3

387

2915

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.1

6.3

284

N05AB04

ATC

prochlorperazine; systemic, rectal

1.9

6.3

379

N06

ICPC

Sensation disturbance other

1.9

6.3

386

SPAT1385

SPAT

Extensive health check-up on fifth grade

1.4

6.3

263

1866

OAA31, ,

SPAT

1.6

6.3

121

729

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.3

6.3

377

2832

N05AF01

ATC

flupentixol; systemic

2.0

6.3

325

SPAT1383

SPAT

Extensive health check-up at 4 years of age

1.4

6.3

233

1620

OAA60, ,

SPAT

1.8

6.2

501

SFA10

NOMESCO Finland

One-surface restoration

1.1

6.2

5227

48950

B27.9

ICD-10 Finland

Infectious mononucleosis, unspecified

1.9

6.2

388

SXC05

NOMESCO Finland

Other oral or dental procedure

1.2

6.2

730

5951

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.0

6.2

286

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.2

6.2

221

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

2.9

6.2

R05CB02

ATC

bromhexine; systemic

2.2

6.2

234

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

6.2

116

695

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

2.0

6.2

320

SPAT1139

SPAT

Nutrition survey

1.5

6.2

175

1154

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.4

6.2

215

1477

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.2

6.2

601

4801

B08.5

ICD-10 Finland

Enteroviral vesicular pharyngitis

2.8

6.2

102

D93

ICPC

Irritable bowel syndrome

1.6

6.2

117

703

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

6.2

2562

23073

C07AB12

ATC

nebivolol; oral

1.6

6.1

132

818

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.4

6.1

248

1750

U71

ICPC

Cystitis/urinary infection other

1.3

6.1

468

3631

SPAT1384

SPAT

Extensive health check-up on first grade

1.4

6.1

236

1652

XX2CT

NOMESCO Finland

Other injection with CT guidance

3.4

6.1

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

1.6

6.1

119

720

S01AX11

ATC

[U] ofloxacin

1.6

6.1

141

889

NG1BG, ,

SPAT

1.3

6.1

383

2897

NG1BA, ,

SPAT

1.5

6.1

152

976

130

Kela drug reimbursment

Malignant tumour

0.6

6.1

131

2004

N02CD01

ATC

erenumab; parenteral

1.8

6.1

491

UJH02

NOMESCO Finland

Anoscopy

1.5

6.1

196

1328

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

2.5

6.1

143

N30.0

ICD-10 Finland

Acute cystitis

1.2

6.1

1289

11085

R03DX10

ATC

benralizumab; systemic

7.5

6.0

G44.8

ICD-10 Finland

Other specified headache syndromes

1.6

6.0

138

868

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

1.7

6.0

543

E66.9

ICD-10 Finland

Obesity, unspecified

1.4

6.0

277

1998

SPAT1284

SPAT

Extensive health certificate

1.4

6.0

214

1476

R2110

NOMESCO Finland

Giving the first information

1.3

6.0

461

3579

WX723

NOMESCO Finland

CPAP therapy

1.4

6.0

247

1749

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

215

29.25

319.71

1.1

0.56

0.30

u/ml

0.27

215

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

260

118

22.28

307.65

1.1

1.0

4.00

2.05

u/ml

0.34

139

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

286

32.96

307.65

1.0

0.25

0.50

u/ml

0.23

179

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

278

121

23.27

307.65

1.1

2.48

3.89

u/ml

0.34

223

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

436

417

10.74

307.65

1.1

1.0

15.76

10.39

u/ml

2.88

270

290

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1474

4960

3.27

307.65

1.6

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1902

2487

9.10

307.65

1.2

1.1

2.75

1.88

u/ml

2.41

1341

1197

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1791

2500

8.41

307.65

1.2

1.1

1.30

1.08

u/ml

0.60

1226

1030

(3005322) IgE [Units/volume] in Serum or Plasma

2534

6838

4.57

307.65

1.6

1.3

486.77

196.44

u/ml

7.91

2446

6338

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1374

2085

7.39

307.65

1.1

6.81

5.25

u/ml

1.42

895

893

(3011841) English Walnut IgE Ab [Units/volume] in Serum

296

112

26.83

307.65

1.1

5.00

5.76

u/ml

0.10

237

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

2040

2967

8.28

307.65

1.2

1.1

2.62

2.55

u/ml

0.08

1353

1506

(3003888) Timothy IgE Ab [Units/volume] in Serum

1991

2562

9.35

307.65

1.2

1.1

7.87

5.49

u/ml

5.19

1520

1320

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1232

1874

7.26

307.65

1.1

1.0

0.56

0.27

u/ml

1.17

628

487

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

250

122

20.70

307.65

1.1

1.0

0.69

1.63

u/ml

0.45

141

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1468

2222

7.48

307.65

1.1

6.55

3.20

u/ml

5.99

1024

1063

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

507

668

7.83

307.65

1.4

1.2

6.28

2.08

u/ml

4.69

337

346

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

459

208

22.76

307.65

1.2

1.1

8.58

11.74

u/ml

0.27

332

118

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

237

27.18

307.65

1.1

1.0

1.56

1.65

u/ml

0.03

183

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

222

118

18.95

278.78

1.1

1.0

0.52

0.33

u/ml

0.25

123

(3027231) Wheat IgE Ab [Units/volume] in Serum

288

261

11.17

268.54

1.2

1.1

8.41

1.97

u/ml

1.03

248

237

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

177

28.18

260.13

1.0

0.80

3.34

u/ml

0.56

142

(3012494) Peanut IgE Ab [Units/volume] in Serum

328

385

8.65

252.98

1.2

1.1

20.36

2.97

u/ml

1.26

259

231

(3019420) Tryptase [Mass/volume] in Serum or Plasma

377

554

6.93

239.47

1.3

1.5

5.35

6.69

ug/l

1.87

347

500

(3013115) Eosinophils [#/volume] in Blood

6166

44675

1.96

215.45

6.6

7.3

0.23

0.18

e9/l

47.40

5487

39816

(3006315) Basophils [#/volume] in Blood

5938

43214

1.89

195.85

6.4

7.0

0.04

e9/l

7.45

5217

37917

(3001604) Monocytes [#/volume] in Blood

5933

43169

1.89

195.77

6.4

7.0

0.54

e9/l

0.47

5220

37915

(3019198) Lymphocytes [#/volume] in Blood

6067

44519

1.89

194.29

6.4

6.9

2.01

e9/l

0.22

5459

40001

(3019069) Monocytes/Leukocytes in Blood

5563

39737

1.87

193.60

6.5

7.1

8.29

8.40

2.74

5270

37715

(3018010) Neutrophils/Leukocytes in Blood

5668

40751

1.87

192.96

6.2

6.8

54.60

55.54

8.90

5428

39302

(3006504) Eosinophils/Leukocytes in Blood

5550

39644

1.87

192.82

6.4

7.1

3.38

2.78

54.13

5249

37589

(3022096) Basophils/Leukocytes in Blood

5537

39574

1.86

191.44

6.5

7.1

0.71

0.68

5.77

5239

37461

(3002030) Lymphocytes/Leukocytes in Blood

5700

41411

1.85

183.71

6.4

6.9

30.44

30.27

0.67

5461

39698

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

126

19.34

160.12

1.0

22.18

18.67

u/ml

0.19

105

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

255

395

6.51

153.78

1.1

13.05

10.49

u/ml

0.41

100

(3013650) Neutrophils [#/volume] in Blood by Automated count

6211

47959

1.75

146.21

8.0

9.8

3.79

3.94

e9/l

8.02

5436

41906

(3020874) Milk IgE Ab [Units/volume] in Serum

404

986

4.17

145.14

1.3

1.1

7.65

0.92

u/ml

2.11

254

348

(3016031) Almond IgE Ab [Units/volume] in Serum

137

103

13.28

143.41

1.0

1.1

1.47

0.49

u/ml

1.71

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

131

13.21

136.70

1.1

1.0

11.11

7.91

u/ml

0.53

105

(3014599) Egg white IgE Ab [Units/volume] in Serum

382

969

4.00

130.12

1.4

1.1

11.78

3.83

u/ml

0.88

228

266

(3015076) Soybean IgE Ab [Units/volume] in Serum

359

879

4.14

128.31

1.1

1.0

1.26

1.40

u/ml

0.07

214

226

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1424

7340

2.07

124.04

4.2

3.7

31.45

31.92

0.90

1012

5428

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

108

13.12

112.35

1.9

1.4

13.35

5.33

u/ml

0.63

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

7115

59140

1.67

106.77

4.6

4.1

8.57

8.93

mm/h

2.23

6717

56181

(3007164) IgA [Mass/volume] in Serum or Plasma

3263

22590

1.63

104.28

1.6

1.5

2.12

2.11

g/l

0.08

2011

14735

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3630

26137

1.58

96.65

1.5

1.4

1.36

1.77

u/ml

1.44

920

7424

(3019225) pH of Specimen

1016

5424

1.94

77.90

3.5

3.6

7.36

7.35

1.42

667

3948

(40768797) Stomach Pathology biopsy report

1569

9674

1.71

74.66

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2195

14755

1.60

74.36

2.9

2.8

90.16

116.68

ug/g

5.22

1710

11842

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

10.89

73.21

1.0

1.1

0.06

u/ml

0.01

(3036312) Salmon IgE Ab [Units/volume] in Serum

10.31

72.29

1.1

3.74

1.70

u/ml

0.51

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3817

29162

1.47

70.39

2.1

1.9

99.63

98.14

pmol/l

1.18

2149

16123

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

102

150

6.76

64.64

1.0

0.02

u/ml

0.12

(44813793) Dust mix specific IgE antibody measurement

263

835

3.16

63.55

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

623

2998

2.12

63.31

1.3

1.2

3.85

4.64

1.60

506

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

233

690

3.38

63.06

2.7

1.8

2.96

3.13

u/ml

0.07

110

197

(3037522) Nuclear Ab [Titer] in Serum

1962

13343

1.56

61.60

1.5

1.4

494.22

537.65

titre

0.40

360

2600

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9091

83980

1.86

58.65

13.7

12.0

18.96

20.76

mg/l

6.59

7419

66466

(36660697) Celiac disease serology panel - Serum

1429

9201

1.62

56.08

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2315

16709

1.48

53.77

1.4

1.3

19.92

25.38

iu/ml

1.71

572

4702

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2490

18266

1.46

53.09

2.1

2.0

0.85

0.99

mg/l

1.33

1795

13489

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7668

68407

1.47

52.75

4.9

4.4

14.43

pmol/l

0.08

7114

64078

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8543

77979

1.60

52.72

6.0

5.2

1.73

1.77

mu/l

2.76

8073

74481

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

591

3001

2.00

51.71

1.7

1.9

1.18

g/l

0.26

563

2899

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

576

2911

2.01

51.07

1.7

2.0

0.22

0.23

g/l

0.11

546

2801

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5679

48243

1.38

50.46

3.6

3.3

84.26

81.08

ug/l

0.22

5390

46121

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4538

37194

1.38

50.35

2.8

2.6

74.61

72.53

nmol/l

5.79

4228

35132

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2132

15327

1.47

49.96

1.4

1.3

6.28

8.54

u/ml

1.46

791

6469

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6584

57467

1.39

48.49

7.4

7.5

76.22

76.84

u/l

0.51

6229

54880

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

371

1614

2.32

48.21

1.2

1.1

1.90

2.51

0.49

315

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

250

903

2.77

48.02

1.1

7.83

6.85

iu/ml

0.21

248

(3047007) Chlamydophila sp Ab [Presence] in Serum

388

1729

2.26

47.64

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1327

8709

1.58

47.43

2.2

355.68

376.42

nmol/l

3.56

1221

8161

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3761

30193

1.37

46.15

5.8

7.0

1.22

mmol/l

2.66

3454

28347

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

14.33

45.99

1.0

1.40

0.24

u/ml

1.16

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1026

6429

1.64

44.24

2.6

2.3

17.74

18.64

au/ml

0.19

148

844

(3019550) Sodium [Moles/volume] in Serum or Plasma

8650

79787

1.56

44.12

12.9

12.3

139.61

mmol/l

0.05

8454

78078

(3025018) Bordetella pertussis Ab [Titer] in Serum

239

882

2.71

44.07

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

970

6004

1.66

43.87

1.4

1.3

45.70

45.37

au/ml

0.02

327

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

13.52

43.45

1.0

1.1

0.27

0.05

u/ml

0.54

(3023103) Potassium [Moles/volume] in Serum or Plasma

8656

79944

1.55

42.89

13.1

12.4

3.90

3.92

mmol/l

11.69

8421

78018

(3007853) Bacteria identified in Skin by Aerobe culture

1404

9535

1.53

42.69

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

648

3617

1.82

42.36

1.6

1.7

7.97

10.34

u/ml

1.21

152

1055

(3000494) Fungus identified in Specimen by Culture

1400

9520

1.52

42.28

1.6

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4125

33984

1.34

41.17

6.2

7.2

1.22

mmol/l

2.94

3572

29873

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2953

23138

1.37

40.95

3.0

2.8

18.75

51.00

ng/l

2.35

1398

11160

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2642

20390

1.38

40.09

2.6

2.4

2.48

2.59

mg/l

2.31

2284

17881

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

128

346

3.68

39.91

1.2

109.67

108.30

0.24

121

315

(3021960) Folate [Moles/volume] in Serum or Plasma

2360

17905

1.39

39.63

1.7

1.6

19.69

19.83

nmol/l

0.20

2048

15921

(3025468) Yersinia sp identified in Specimen by Organism specific culture

219

817

2.68

39.56

1.4

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

249

990

2.52

39.51

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

219

823

2.66

39.00

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

219

824

2.66

38.91

1.4

1.5

—

(3022145) Colonoscopy Study observation

1248

8418

1.53

38.90

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

225

859

2.62

38.83

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

226

865

2.61

38.80

1.4

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

250

1009

2.48

38.44

1.5

1.4

6.38

6.51

g/l

0.33

216

725

(3024139) IgG subclass 3 [Mass/volume] in Serum

250

1009

2.48

38.44

1.5

1.4

0.34

0.37

g/l

0.80

216

719

(3028192) IgG subclass 2 [Mass/volume] in Serum

250

1010

2.48

38.35

1.5

1.4

2.95

2.87

g/l

0.33

217

726

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

379

3.49

38.33

1.3

1.2

0.29

g/l

0.07

102

309

(3028026) IgM [Mass/volume] in Serum or Plasma

885

5534

1.63

38.23

1.9

1.23

1.25

g/l

0.18

815

5196

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

408

2026

2.03

37.90

1.5

26.55

11.43

iu/ml

0.64

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

432

2192

1.99

37.76

1.2

1.1

18.58

16.06

au/ml

0.22

624

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

227

884

2.57

37.63

1.4

1.5

—

(4062490) Immunoglobulin typing, IgG

246

997

2.47

37.49

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

544

2998

1.83

37.00

1.9

1.7

23.46

11.53

iu/ml

0.60

120

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1033

6767

1.56

36.63

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6951

62264

1.34

36.34

3.4

3.2

35.97

36.59

u/l

0.35

6627

59923

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2490

19307

1.36

35.94

2.2

150.10

216.54

u/l

5.67

2357

18502

(3019309) Folate [Moles/volume] in Red Blood Cells

1262

8676

1.50

35.71

1.7

1079.09

1158.08

nmol/l

2.49

926

6845

(3005719) IgG [Mass/volume] in Serum or Plasma

1073

7131

1.54

35.62

2.8

2.9

10.21

10.41

g/l

1.11

992

6660

(3037467) Urinalysis macro (dipstick) panel - Urine

6351

56236

1.32

35.48

4.5

4.1

2.46

11.51

0.54

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8206

75578

1.42

35.22

11.3

10.5

94.75

94.66

ml/min/173m2

0.15

7323

67472

(3021589) Normoblasts [#/volume] in Blood

4518

38414

1.29

33.22

9.5

10.3

0.00

e9/l

1.47

3590

31382

(40768443) Skin Pathology biopsy report

544

3119

1.76

32.36

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

501

2807

1.80

32.24

1.3

61.40

33.93

u/ml

0.79

167

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

471

2599

1.83

31.87

1.3

14.10

11.95

u/ml

0.15

376

(3013139) Helicobacter pylori Ag [Presence] in Stool

902

5908

1.56

31.81

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

471

2605

1.82

31.63

1.3

10.48

7.08

u/ml

0.17

241

(3031040) Bacteria [#/volume] in Urine by Automated count

6016

53255

1.29

31.55

4.5

4.1

2336.57

1408.99

e6/l

0.47

655

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

151

4.73

31.48

1.1

1.03

0.52

u/ml

0.72

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

477

2665

1.80

30.98

1.5

1.4

—

(3022313) Gas panel - Capillary blood

607

3657

1.68

30.14

3.5

6.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

565

3351

1.70

29.75

1.8

2.0

38.93

39.97

u/l

0.69

517

3117

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9209

87268

1.61

29.47

14.8

13.5

69.98

70.02

umol/l

0.07

9103

86331

(3024980) IgG subclass 4 [Mass/volume] in Serum

327

1645

1.99

29.31

1.7

1.6

0.81

0.70

g/l

1.01

288

1293

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

166

629

2.63

29.18

1.3

1.2

33.20

53.04

u/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

128

425

2.99

28.82

2.0

2.4

173.66

92.33

ug/l

0.22

123

397

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4393

37653

1.27

28.63

5.2

6.1

11.00

11.02

umol/l

0.02

4118

35659

(3023419) Bacteria identified in Sputum by Culture

161

612

2.62

28.13

2.5

3.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

186

758

2.45

28.10

1.3

1.2

106.12

41.40

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7978

73806

1.34

27.75

4.3

3.8

5.59

5.64

mmol/l

2.79

7467

69841

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

385

2094

1.85

27.29

1.3

1.50

3.10

u/ml

1.05

132

(3009343) pH of Capillary blood

761

4967

1.55

27.12

3.4

5.6

7.41

0.39

607

4115

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1714

13019

1.36

27.12

2.9

3.1

687.42

744.15

ng/l

0.20

1300

10557

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

771

5074

1.54

26.46

3.5

5.6

5.04

5.10

kpa

1.88

742

4899

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

169

680

2.48

26.27

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

977

6765

1.47

26.22

4.0

5.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

381

2094

1.83

26.12

1.8

2.1

10.80

10.83

mg/l

0.03

350

1995

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

401

2239

1.80

26.10

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9194

87366

1.55

25.78

10.9

10.0

26.89

26.68

u/l

0.45

8974

85529

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

8.32

24.42

1.2

1.1

0.46

1.61

u/ml

0.50

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7688

71091

1.30

24.35

5.1

4.6

37.02

37.14

mmol/mol

0.62

7285

68172

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

530

3257

1.64

24.33

3.6

6.3

24.32

24.39

mmol/l

0.26

500

3141

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1385

10388

1.37

23.43

1.9

1.8

—

(3007461) Platelets [#/volume] in Blood

9689

93590

2.18

23.17

20.6

18.4

266.23

262.34

e9/l

8.39

9551

91940

(3035941) MCH [Entitic mass]

9691

93631

2.18

22.92

20.5

18.3

29.98

0.04

9642

92955

(3000963) Hemoglobin [Mass/volume] in Blood

9694

93675

2.19

22.85

20.7

18.5

136.90

136.49

g/l

2.60

9648

93004

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

9691

93640

2.17

22.76

20.9

18.7

41.29

41.42

0.11

9643

92916

(3026361) Erythrocytes [#/volume] in Blood

9691

93645

2.17

22.67

20.5

18.3

4.59

4.58

e12/l

2.77

9532

91841

(3010813) Leukocytes [#/volume] in Blood

9692

93669

2.17

22.49

20.6

18.4

6.71

6.69

e9/l

0.35

9533

91838

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2396

19504

1.28

22.44

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2621

21608

1.27

22.04

4.2

4.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

242

1213

1.99

22.00

1.2

21.33

25.51

u/ml

0.14

(3024731) MCV [Entitic mean volume] in Red Blood Cells

9686

93620

2.12

21.95

20.5

18.3

89.63

89.65

0.09

9637

92942

(3017732) Neutrophils [#/volume] in Blood

1375

10408

1.35

21.81

2.5

3.0

4.25

4.40

e9/l

0.60

1126

9373

(3023420) DNA double strand Ab [Units/volume] in Serum

605

3946

1.54

21.56

1.8

2.0

9.05

6.71

iu/ml

0.70

117

963

(3022948) Iron [Moles/volume] in Serum or Plasma

1578

12214

1.33

21.48

2.4

2.5

14.93

14.50

umol/l

1.65

1487

11529

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

675

4514

1.51

21.41

3.5

5.7

0.87

1.26

mmol/l

2.68

473

3245

(3044640) Blood type and Crossmatch panel - Blood

3052

25713

1.25

21.04

2.2

2.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

101

4.60

20.05

1.0

1.04

0.08

u/ml

2.17

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1450

11189

1.33

20.04

2.4

2.5

2.49

2.46

g/l

1.36

1355

10435

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1165

8702

1.36

20.03

1.3

125.33

142.85

u/ml

0.78

432

3326

(3020961) Endomysium IgA Ab [Titer] in Serum

850

6027

1.43

19.91

1.2

201.88

179.73

titre

0.07

201

(3038026) Centromere Ab [Units/volume] in Serum

134

553

2.41

19.83

1.3

1.2

26.72

44.68

u/ml

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3530

30405

1.22

19.34

4.8

5.2

37.60

37.27

g/l

3.50

3302

28796

(3013826) Glucose [Moles/volume] in Serum or Plasma

4913

43734

1.21

19.31

4.5

5.0

6.27

6.33

mmol/l

0.88

4569

40207

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

202

1002

2.01

18.97

1.1

15.03

16.61

u/ml

0.37

427

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

282

1561

1.80

18.96

2.8

2.2

0.55

0.61

g/l

0.16

240

1408

(4015189) Microbial culture of sputum

5.01

18.85

3.2

2.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2147

17555

1.26

18.84

2.4

2.5

318.81

318.51

umol/l

0.05

1920

16144

(3015377) Calcium [Moles/volume] in Serum or Plasma

2830

23883

1.24

18.70

2.6

3.2

2.35

mmol/l

0.36

2545

22226

(1002224) Polysomnography panel

709

4919

1.45

18.66

1.1

—

(3045424) Erythrocytes [Presence] in Urine

555

3667

1.52

18.62

2.0

0.02

0.20

estimate

0.54

122

1426

(40758558) Short blood count panel - Blood

2872

24313

1.23

18.35

5.3

6.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

430

2699

1.60

18.12

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

344

2042

1.68

18.09

1.4

314.73

308.64

ug/g

0.18

156

1058

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

645

2.23

18.09

1.9

19.72

23.77

mg/l

0.54

251

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1313

10136

1.32

17.95

2.5

2.6

24.30

23.96

0.43

1228

9526

(3024891) Influenza virus A+B Ag [Presence] in Specimen

478

3094

1.55

17.63

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

428

2703

1.59

17.58

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

7.14

17.45

1.0

12.86

0.59

u/ml

2.33

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

1720

1.73

17.38

2.5

2.2

2.80

2.87

g/l

0.64

268

1626

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

784

5614

1.41

17.32

1.2

21.61

8.91

u/ml

0.25

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

473

3069

1.55

17.26

1.1

3.52

5.46

eliau/ml

0.96

462

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

513

3394

1.52

17.11

1.6

—

(3023368) Bacteria identified in Blood by Culture

2029

16647

1.25

17.05

3.7

4.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

7.26

17.05

1.0

1.1

0.20

0.01

u/ml

1.14

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

221

1182

1.86

16.66

1.5

1.3

103.33

266.67

titre

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

109

446

2.42

16.52

4.1

4.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

361

2222

1.62

16.51

1.5

1.4

18.49

20.50

u/l

0.64

280

1852

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2770

23570

1.22

16.45

2.6

2.7

54.47

57.88

u/l

2.38

2545

22043

(3004588) Protein electrophoresis panel - Serum or Plasma

455

2966

1.54

16.27

2.5

2.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

544

3689

1.48

16.10

1.3

0.41

0.97

u/ml

1.69

264

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

216

1162

1.85

16.00

1.5

1.3

465.45

393.64

titre

0.11

103

(3033658) Prothrombin time (PT) actual/Normal

2314

19415

1.23

15.63

3.9

4.4

95.68

94.20

2.52

2256

18963

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

1793

1.67

15.43

2.6

2.1

6.95

7.21

g/l

1.95

270

1698

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

270

1570

1.71

15.38

2.4

2.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

143

677

2.10

15.33

1.4

1.8

21.73

21.61

umol/l

0.02

136

636

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

1792

1.66

15.22

2.6

2.1

4.27

4.28

g/l

0.07

270

1697

(3045683) HLA typing for celiac disease panel - Blood or Tissue

152

739

2.04

15.18

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

590

4118

1.44

15.03

2.6

67.40

67.13

g/l

0.40

531

3889

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

1791

1.66

15.01

2.6

2.1

3.76

3.69

g/l

0.35

270

1698

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

161

3.32

14.75

1.3

1.74

1.53

iu/ml

0.37

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

858

6406

1.35

14.62

3.0

3.6

4.70

4.65

pmol/l

0.53

758

5866

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

243

1393

1.74

14.59

2.5

2.1

0.01

g/l

0.18

214

1289

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

358

2273

1.57

14.42

1.2

1.3

47.37

43.25

u/ml

0.12

197

(3014765) Yersinia sp identified in Stool by Organism specific culture

372

2391

1.55

14.21

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

232

1325

1.74

14.13

2.6

2.1

0.01

0.00

g/l

0.44

202

1190

(3025941) Bacteria identified in Stool by Culture

737

5402

1.37

14.13

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8252

78197

1.25

14.03

4.4

4.0

1.45

1.46

mmol/l

1.77

7813

74967

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8321

78925

1.25

14.02

4.7

4.4

2.81

2.82

mmol/l

0.74

7883

75632

(42529406) Shigella sp [Presence] in Stool by Culture

373

2406

1.55

14.02

1.1

—

(3033099) Centromere Ab [Titer] in Serum

188

3.05

13.83

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

387

2527

1.53

13.77

2.1

2.0

—

(3042936) Bacteria identified in Isolate by Culture

1253

9937

1.28

13.74

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

219

1242

1.75

13.68

2.7

2.1

0.00

g/l

-0.00

202

1188

(3007700) Barley IgE Ab [Units/volume] in Serum

4.36

13.68

1.1

0.64

0.50

u/ml

0.11

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

135

3.44

13.63

1.3

0.53

iu/ml

0.01

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8283

78589

1.24

13.51

4.4

4.1

4.69

4.71

mmol/l

1.20

7869

75624

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1530

1.67

13.47

2.5

2.1

10.09

10.29

g/l

0.35

223

1426

(3015736) pH of Urine

4062

36273

1.18

13.38

3.1

6.21

6.23

0.45

2188

20529

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

367

2386

1.54

13.33

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

315

1980

1.59

13.28

1.7

1.6

356.52

380.05

mu/l

0.61

244

1624

(3032080) INR in Blood by Coagulation assay

3112

27226

1.19

12.99

8.2

8.4

1.09

1.12

inr

3.59

2475

22589

(3017446) Testosterone [Moles/volume] in Serum or Plasma

906

6955

1.31

12.71

2.6

2.3

12.25

11.99

nmol/l

0.40

831

6427

(3048929) Epstein Barr virus Ab [Presence] in Serum

757

5667

1.34

12.65

1.3

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

4.10

12.64

1.1

1.0

0.73

0.13

u/ml

1.11

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

2290

1.53

12.37

2.0

1.9

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

15.64

12.01

1.1

0.01

1.02

u/ml

0.88

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2631

22824

1.19

11.90

2.5

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7778

73571

1.20

11.73

3.8

3.5

1.25

1.23

mmol/l

1.05

7317

70279

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

1.11

1.43

mg/l

0.54

110

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

1.90

2.01

mg/l

0.06

107

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

3.10

2.63

mg/l

0.20

105

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

4.28

4.19

mg/l

0.03

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

3.46

3.14

mg/l

0.14

102

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

1.10

1.66

mg/l

0.63

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

2.00

1.87

mg/l

0.07

101

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

1.14

1.19

mg/l

0.05

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

140

3.18

11.55

1.8

1.23

0.93

mg/l

0.33

103

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3553

31680

1.16

11.32

1.8

1.36

mmol/l

0.08

3070

28072

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

476

3367

1.41

11.30

2.0

1.8

39.31

39.66

nmol/l

0.10

465

3310

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

212

1259

1.67

11.29

1.1

1.40

1.45

g/l

1.20

186

1168

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

282

1800

1.56

11.19

1.1

3.37

3.24

eliau/ml

0.05

133

895

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

143

3.11

11.17

1.8

1.08

1.44

mg/l

0.35

103

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

306

2.39

11.11

1.6

1.4

27.42

19.41

u/ml

0.31

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

215

2.67

10.92

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2813

24687

1.17

10.87

2.6

2.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

639

4779

1.34

10.75

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

567

4164

1.36

10.75

1.6

3.82

4.20

mg/l

0.51

422

2950

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

155

855

1.80

10.74

2.4

3.1

219.87

207.35

e6/l

0.37

124

662

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

152

838

1.80

10.56

2.3

3.0

565.32

542.05

e6/l

0.23

118

626

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

935

7382

1.27

10.54

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

272

2.44

10.49

1.6

1.3

23.33

64.58

titre

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

866

6783

1.28

10.40

2.9

2.8

0.23

0.22

g/l

1.62

811

6393

(3013005) Retinol [Moles/volume] in Serum or Plasma

125

653

1.90

10.31

2.3

2.6

1.89

1.79

umol/l

0.94

117

614

(3008898) HLA-B27 [Presence]

612

4581

1.34

10.25

1.1

—

(4146454) Self-monitoring of blood glucose

472

2.06

10.20

3.3

2.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

300

2.34

10.19

1.2

—

(3018095) Leukocytes [#/volume] in Urine

3292

29382

1.16

10.02

3.9

3.8

40.13

66.35

e6/l

3.29

2134

19367

(3017958) Strawberry IgE Ab [Units/volume] in Serum

5.20

9.90

1.0

0.26

0.04

u/ml

0.78

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1432

11936

1.21

9.81

2.2

2.6

2.41

2.42

mmol/l

0.85

1262

10677

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1354

11230

1.22

9.75

3.4

4.6

0.83

0.82

mmol/l

1.36

1263

10700

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

946

7560

1.26

9.62

2.3

2.6

35.66

43.87

u/l

0.63

799

6459

(3009214) Lutropin [Units/volume] in Serum or Plasma

649

4947

1.31

9.58

1.6

1.5

8.20

8.67

u/l

0.49

506

3889

(3009261) Glucose [Presence] in Urine by Test strip

4904

45099

1.14

9.56

3.5

0.00

0.16

estimate

0.75

877

9027

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

323

2.24

9.45

1.1

25.06

32.64

iu/ml

0.63

323

(3030467) Casts [#/volume] in Urine by Automated count

2364

20664

1.17

9.35

3.2

3.1

0.20

0.30

e6/l

3.51

1630

14649

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

247

1597

1.54

9.32

1.8

608.00

2596.36

titre

—

(3045414) Leukocytes [Presence] in Urine

889

7082

1.26

9.28

2.0

0.01

0.04

estimate

1.37

161

1734

(3021440) Promyelocytes/Leukocytes in Blood

821

6489

1.27

9.16

4.2

5.0

0.08

0.12

0.70

184

1559

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

165

979

1.67

8.91

1.2

—

(3011412) CD3 cells [#/volume] in Blood

174

1047

1.65

8.91

2.4

2.9

1463.97

1341.39

e6/l

1.10

143

852

(3021601) Nitrite [Presence] in Urine by Test strip

4825

44453

1.14

8.86

3.4

0.00

estimate

0.09

899

9293

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

153

895

1.70

8.73

1.1

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

851

6798

1.26

8.68

3.1

3.5

1.61

1.68

1.16

736

6219

(3035933) Granulocytes/Leukocytes in Blood

306

2099

1.45

8.68

2.6

3.3

55.94

56.94

0.78

306

2099

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

4.81

8.64

1.1

1.0

0.92

0.47

u/ml

0.39

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

144

834

1.71

8.53

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

464

3428

1.35

8.52

1.6

0.12

5.90

iu/ml

0.51

585

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

149

873

1.69

8.46

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

146

851

1.70

8.45

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

219

1411

1.54

8.44

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

219

1411

1.54

8.44

1.2

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3198

28747

1.14

8.42

3.0

3.4

30.28

31.37

u/l

0.53

3029

27439

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

4.69

8.40

1.0

0.68

0.42

u/ml

0.27

(3002179) Metamyelocytes/Leukocytes in Blood

811

6470

1.26

8.37

3.8

4.7

0.65

0.60

0.21

206

1726

(3017181) Myelocytes/Leukocytes in Blood

841

6739

1.25

8.35

4.2

4.9

0.71

0.84

0.73

205

1807

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

710

5585

1.27

8.25

7.6

11.2

24.74

24.72

mmol/l

0.05

704

5559

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

148

872

1.68

8.25

1.2

—

(3002256) Pathology report gross observation

1169

9731

1.21

8.05

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

261

1763

1.47

8.05

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

140

820

1.69

7.99

1.1

1.2

—

(3025159) Blasts/Leukocytes in Blood

827

6654

1.25

7.92

4.3

5.2

0.51

0.24

175

1496

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1567

13424

1.18

7.81

1.6

17943371.74

33566443.08

pmol/l

0.88

1332

11747

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

205

1327

1.53

7.77

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

159

2.61

7.70

1.3

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

146

874

1.66

7.69

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

2628

23429

1.14

7.68

3.5

3.6

8.44

8.30

mmol/l

0.64

2255

20853

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

304

2135

1.42

7.63

2.1

2.5

372.72

419.23

ug/l

0.10

263

1968

(3035350) Ketones [Presence] in Urine by Test strip

4842

44887

1.12

7.50

3.5

3.15

3.50

estimate

0.05

906

9308

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

437

5624

0.76

7.48

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1396

11888

1.18

7.45

2.9

3.32

3.55

e6/l

0.27

626

5476

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

413

3067

1.34

7.37

1.2

1.4

83.72

38.70

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

497

1.85

7.29

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

240

1628

1.46

7.28

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1102

9218

1.20

7.19

2.4

3.2

5.67

6.68

umol/l

1.70

959

7906

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

388

2866

1.35

7.19

2.3

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

619

4872

1.27

7.18

3.8

4.7

67.37

75.22

ng/l

2.34

555

4426

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

315

2256

1.39

7.09

2.3

1.9

202.78

198.04

pmol/l

0.31

306

2161

(3023520) Reticulocytes [#/volume] in Blood

618

4873

1.27

7.07

2.6

3.2

70.00

70.82

e9/l

0.23

428

3381

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

340

4496

0.74

7.03

1.5

60.81

60.46

ug/l

0.06

340

4496

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1481

12734

1.17

7.01

2.8

2.7

0.75

1.03

e6/l

2.79

717

6363

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

869

7128

1.22

6.94

1.8

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

768

6225

1.23

6.88

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

699

1.67

6.54

3.0

3.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

216

2.24

6.52

1.0

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

2648

23831

1.13

6.49

3.2

44.23

67.91

e6/l

0.94

1931

17706

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

241

2.13

6.15

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

241

2.13

6.15

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

207

1416

1.45

6.09

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1623

14204

1.15

6.03

1.7

1.8

1.35

1.38

1.25

1448

12832

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

329

2438

1.34

6.03

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

176

1169

1.49

6.01

1.8

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

180

2.31

6.00

3.9

4.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

844

7005

1.21

5.99

3.6

4.9

225.55

237.45

u/l

1.76

795

6704

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

144

2.47

5.98

1.9

1.6

0.34

0.41

ug/l

0.74

113

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

135

848

1.58

5.95

2.2

2.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

366

1.89

5.95

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.92

5.91

2.9

1.9

38.93

45.36

umol/l

0.33

(3010838) Calcium [Moles/time] in 24 hour Urine

186

1258

1.47

5.82

2.1

2.0

5.15

5.30

mmol/24h

0.27

167

1157

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

382

2909

1.31

5.80

1.2

1.4

240.88

231.01

u/ml

0.30

212

1783

(37208534) Antinuclear antibody arbitrary concentration in serum

370

1.87

5.77

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

406

3124

1.29

5.71

3.0

3.4

167.45

171.60

0.49

390

2991

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

239

1707

1.39

5.56

1.3

4.29

4.18

u/ml

0.04

115

811

(3023323) Follitropin [Units/volume] in Serum or Plasma

998

8467

1.18

5.54

1.5

18.69

21.71

iu/l

2.74

833

7099

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1179

10160

1.16

5.39

2.4

2.8

29.11

29.38

1.14

1135

9886

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

4.79

5.34

1.0

0.94

0.15

u/ml

—

(3036489) Thrombin time

463

3653

1.26

5.34

2.5

3.0

20.66

20.73

0.10

405

3178

(3004716) Salmonella sp identified in Stool by Organism specific culture

753

6268

1.20

5.20

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1932

17278

1.13

5.10

3.7

60.03

58.83

mg/l

0.03

1143

11275

(3027020) Pear IgE Ab [Units/volume] in Serum

13.15

5.03

1.0

0.51

0.28

u/ml

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

751

6274

1.19

5.00

2.9

2.5

0.61

0.66

ug/l

0.65

374

3118

(3006462) Nitrate [Presence] in Urine

318

1.87

4.96

3.1

2.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

419

1.75

4.94

1.2

98.53

94.65

0.40

186

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

181

1260

1.42

4.93

2.8

3.2

23.73

22.87

nmol/l

0.39

172

1221

(3000060) B lymphocytes [#/volume] in Blood

562

1.64

4.89

2.3

3.0

0.29

0.27

e9/l

0.20

291

(3034770) Mitochondria Ab [Titer] in Serum

342

2632

1.29

4.86

1.2

1.4

2285.71

959.14

titre

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

211

2.06

4.84

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

5.92

4.84

1.0

1.85

8.87

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

564

1.63

4.82

2.8

2.6

—

(3028707) Methadone [Presence] in Urine by Screen method

479

3844

1.24

4.79

2.6

2.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

445

1.71

4.79

1.2

118.53

107.86

1.53

403

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

123

798

1.53

4.79

1.2

1.3

373.08

210.82

titre

0.53

147

(3014051) Protein [Presence] in Urine by Test strip

2848

26103

1.11

4.78

2.6

0.00

0.03

1.67

319

(3017143) Hepatitis C virus Ab [Presence] in Serum

1782

15919

1.13

4.77

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

431

1.72

4.76

1.1

98.92

94.30

1.03

189

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

233

1703

1.36

4.76

1.1

—

(3026782) Osmolality of Urine

1549

13720

1.13

4.76

2.6

2.7

532.82

541.96

mosm/kgh2o

0.77

1334

12028

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1205

10503

1.15

4.71

4.2

3.8

1.63

1.71

ug/l

0.17

1069

9633

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

325

1.82

4.66

1.2

1.3

—

(4211845) Urine protein measurement

354

1.79

4.64

2.9

2.4

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

4.93

4.56

1.0

0.08

0.01

u/ml

0.92

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1325

11650

1.14

4.56

3.4

3.2

246.72

486.65

ng/l

3.38

715

6704

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

118

768

1.52

4.55

1.2

—

(3018418) pH of Serum or Plasma

2182

19769

1.11

4.54

3.7

4.1

7.40

7.39

0.39

1468

13710

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

162

1124

1.43

4.53

1.4

1.3

5.09

6.01

umol/l

2.40

144

1016

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

521

1.63

4.51

1.1

—

(3014271) Vancomycin [Susceptibility]

133

2.30

4.50

2.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

409

1.72

4.49

1.1

57.64

54.90

u/ml

0.13

402

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

331

1.79

4.41

1.2

1.3

—

(3022621) pH of Urine by Test strip

773

6552

1.18

4.37

2.1

2.2

6.21

6.19

0.21

399

4096

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

691

5809

1.19

4.32

1.4

1.3

219.04

229.39

miu/ml

0.34

350

2853

(3020682) Albumin/Creatinine [Ratio] in Urine

1936

17480

1.11

4.27

4.3

9.12

10.59

mg/mmol

0.38

1141

11314

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

143

2.21

4.24

1.1

1.2

20.18

29.21

u/ml

0.59

(3032057) Clostridioides difficile [Presence] in Stool

2.52

4.24

1.6

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3394

31515

1.09

4.23

2.3

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

115

762

1.49

4.11

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1064

9283

1.15

4.11

2.0

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

2556

23458

1.10

4.07

3.5

3.6

0.00

estimate

0.04

866

8887

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

275

1.83

4.07

1.2

80.15

75.24

0.22

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1061

9264

1.14

4.05

5.5

7.4

1.10

1.09

mmol/l

0.56

980

8702

(3037756) Immunofixation for Serum or Plasma

116

775

1.48

4.00

1.8

1.7

—

(3000991) Gas panel - Venous blood

757

6455

1.17

4.00

8.1

10.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

771

6592

1.17

3.94

2.6

2.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

5.48

3.92

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

311

2436

1.27

3.91

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

598

5012

1.19

3.89

4.7

6.0

24.20

24.03

mmol/l

0.81

591

4971

(3007566) Smooth muscle Ab [Titer] in Serum

343

2721

1.25

3.88

1.3

1.4

102.86

115.56

titre

0.18

293

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

124

850

1.44

3.77

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

176

1283

1.36

3.75

3.9

3.4

41.42

48.09

mg/l

0.36

157

1090

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

176

1284

1.36

3.73

3.9

3.4

32.07

47.15

mg/l

0.85

157

1094

(3027008) Opiates [Presence] in Urine

1055

9261

1.14

3.73

2.0

2.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

326

2584

1.25

3.73

1.3

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

620

1.52

3.70

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1049

9214

1.14

3.68

2.0

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

189

1398

1.34

3.67

1.6

1.7

10951.77

11406.58

e6/l

0.04

127

998

(3021387) Prolactin [Units/volume] in Serum or Plasma

764

6569

1.16

3.64

1.7

1.6

308.09

314.11

mu/l

0.18

689

5921

(3000850) Epithelial cells [#/volume] in Urine

1771

16044

1.11

3.63

2.6

6.54

7.17

e6/l

0.99

1563

14505

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

145

1032

1.39

3.59

1.4

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

688

5879

1.17

3.56

7.8

9.2

1.24

1.31

mmol/l

1.45

670

5777

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

165

1202

1.36

3.55

1.2

1.1

97.71

95.74

0.41

154

1141

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

391

3181

1.22

3.53

3.2

3.7

3.45

3.44

g/l

0.06

377

3032

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

929

8121

1.14

3.51

3.3

21.35

21.28

0.04

289

2826

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

410

3354

1.21

3.50

9.5

12.0

24.38

24.14

mmol/l

1.14

400

3300

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

157

1141

1.36

3.44

3.9

3.1

2.56

2.67

ratio

0.04

623

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

276

1.75

3.44

1.2

93.20

87.63

—

(3016879) Cocaine [Presence] in Urine

977

8585

1.14

3.41

2.0

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

349

2824

1.23

3.34

2.2

2.6

4.31

6.20

umol/l

5.95

253

2100

(3017354) Segmented neutrophils/Leukocytes in Blood

619

1.49

3.33

2.5

3.2

58.27

54.17

1.38

544

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

858

0.61

3.33

15.0

17.3

838.87

2311.97

nmol/l

0.49

832

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

104

708

1.45

3.33

1.5

1.2

122.70

117.74

pmol/l

0.49

104

708

(3041806) Other cells [#/volume] in Blood by Manual count

136

974

1.38

3.28

1.6

1.4

0.60

0.51

e9/l

3.11

136

974

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

321

2581

1.23

3.27

1.3

1.6

20.59

21.87

u/ml

—

(3027944) Amphetamines [Presence] in Urine

1036

9169

1.13

3.23

1.8

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

234

1817

1.28

3.23

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

388

1.60

3.20

1.2

1.4

80.90

162.45

nmol/24h

0.59

388

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

497

1.53

3.20

2.7

2.5

9.91

9.35

mg/l

0.49

421

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

154

1131

1.35

3.19

1.2

1.3

0.22

0.29

nmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

517

4361

1.18

3.18

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

190

1441

1.31

3.15

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

233

0.34

3.15

5.0

8.3

—

1811.31

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

516

1.51

3.12

1.7

2.02

2.58

nmol/l

0.31

409

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

1739

1.28

3.11

1.4

1.5

—

(3012501) Base excess in Blood by calculation

182

1375

1.31

3.11

2.8

4.0

2.23

2.10

mmol/l

0.24

100

860

(3001556) Androgen free Index in Serum or Plasma

212

1.82

3.11

1.3

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

209

1609

1.29

3.11

1.2

1.1

118.20

115.00

0.81

191

1479

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

501

1.52

3.10

2.6

3.4

1.05

1.44

ug/l

0.73

478

(3041672) Baker's yeast Ab [Presence] in Serum

116

2.13

3.10

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

228

1777

1.27

3.08

1.3

3.10

3.53

u/ml

0.17

691

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

111

778

1.41

3.07

1.2

1.3

1.67

1.85

mmol/l

3.09

102

721

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

221

1.79

3.04

1.6

9.69

9.10

ug/l

0.37

221

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

144

1.99

3.02

1.2

1.3

243.45

305.51

pmol/l

0.82

104

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

512

1.51

3.02

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

190

2400

0.78

3.02

1.7

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2168

19993

1.09

3.01

3.4

0.90

0.24

—

125

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.75

2.98

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

115

817

1.39

2.95

1.1

287.47

287.82

mg/l

0.02

102

762

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

507

1.50

2.95

1.1

0.09

3.05

nmol/l

1.92

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

224

1.76

2.92

2.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

534

1.48

2.88

2.6

2.4

—

(3011436) Histone Ab [Units/volume] in Serum

154

1.92

2.87

1.0

1.1

—

28.67

—

(3004809) Band form neutrophils/Leukocytes in Blood

137

1007

1.35

2.86

2.9

3.2

1.04

1.37

0.78

120

924

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

346

1.60

2.85

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.29

2.81

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

473

1.50

2.81

2.0

1.9

132.75

144.19

0.77

447

(3044927) Protein electrophoresis panel - Urine

364

1.57

2.78

1.3

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

236

1873

1.25

2.77

1.6

1.7

—

(3016038) Potassium [Moles/volume] in Urine

427

1.53

2.77

1.5

2.0

32.24

35.64

mmol/l

0.52

400

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.29

2.76

1.0

1.1

0.02

0.22

u/ml

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

403

3376

1.18

2.74

2.6

3.8

97.46

95.33

1.23

388

3275

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

508

1.48

2.74

1.7

1.5

4.73

6.11

u/l

2.28

440

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

218

1718

1.26

2.72

1.2

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

125

915

1.35

2.70

1.3

1.2

21.88

33.10

nmol/l

—

(3036603) Volume of Urine

527

1.46

2.67

1.6

2318.45

2125.14

0.83

518

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

658

1.41

2.67

1.2

1.4

180.22

193.32

pmol/l

0.30

658

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

180

1.81

2.65

2.9

1.9

41.59

41.50

g/l

0.03

180

(3011985) Renin [Units/volume] in Plasma

152

1149

1.31

2.65

1.7

66.60

66.13

mu/l

0.01

139

1059

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

307

1.61

2.64

1.3

1.4

10.68

12.16

u/l

0.95

300

(3012544) pH of Venous blood

810

7158

1.13

2.63

4.3

5.5

7.37

0.44

429

4217

(4268621) Lupus anticoagulant assay

166

1272

1.29

2.62

2.2

2.3

—

(1616796) Gas panel - Central venous blood

191

1490

1.27

2.62

3.1

3.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

173

1335

1.28

2.59

1.4

2.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

119

873

1.35

2.56

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

115

840

1.35

2.54

1.6

1.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.43

2.53

1.0

1.6

0.19

0.98

umol/24h

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.94

2.53

1.3

3.3

—

(3019174) dRVVT (LA screen)

2.12

2.51

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

149

1133

1.30

2.51

3.1

3.3

32.94

24.16

mu/l

1.39

139

1072

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2713

25401

1.07

2.50

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

557

4822

1.15

2.50

1.5

1.8

0.21

0.27

mg/l

2.51

224

2178

(3016330) Potassium [Moles/time] in 24 hour Urine

127

1.94

2.49

1.2

1.3

—

99.48

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

444

3788

1.16

2.45

2.0

2.1

6.60

7.12

ug/l

0.25

376

3363

(3006184) Hemoglobin [Mass/volume] in Capillary blood

202

1603

1.25

2.42

1.9

2.2

133.57

133.98

g/l

0.10

142

1321

(3007930) Methemoglobin/Hemoglobin.total in Blood

168

2088

0.79

2.42

4.5

5.5

0.94

0.90

0.52

158

1967

(3006922) Hepatitis E virus Ab [Presence] in Serum

116

857

1.34

2.40

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

102

2.03

2.37

1.9

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

526

4555

1.15

2.37

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

414

3524

1.16

2.36

1.3

—

(3028433) Virus identified in Specimen by Culture

270

1.61

2.36

1.3

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

344

2885

1.18

2.36

4.1

6.9

9.43

9.29

kpa

0.69

334

2809

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

178

1397

1.26

2.36

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

123

920

1.32

2.35

1.2

1.3

—

nmol/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

138

1049

1.30

2.35

1.9

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

3.29

2.35

1.9

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

164

1276

1.27

2.33

1.1

1.13

0.95

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

139

1063

1.29

2.27

1.4

1.5

340.02

526.97

pmol/l

1.10

118

938

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

679

1.37

2.27

1.2

61.68

72.47

u/l

0.37

606

(4195642) Thrombophilia screening test

201

1608

1.24

2.26

1.2

—

(44806420) Estimation of glomerular filtration rate

143

1099

1.29

2.26

2.3

2.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

4.55

2.24

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

329

1.53

2.23

1.8

1.9

—

(3002032) Base excess in Venous blood by calculation

780

6957

1.11

2.20

4.5

5.6

1.68

1.54

mmol/l

0.57

688

5973

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.48

2.19

1.2

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

131

1001

1.29

2.17

1.5

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

156

1.77

2.15

1.0

1.1

81.73

71.60

ug/l

0.60

135

(3030313) Adrenal Ab [Titer] in Serum

156

1.77

2.15

1.3

1.2

—

41.36

—

(3000093) Morphology [Interpretation] in Blood Narrative

653

1.36

2.14

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

721

1.34

2.13

1.7

1.8

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

349

1.50

2.12

1.1

1.2

12.93

16.66

u/l

0.63

318

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

109

815

1.32

2.12

2.4

3.0

103.67

97.51

1.08

104

766

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1004

9089

1.10

2.12

2.5

7362.49

6440.27

u/l

0.36

382

3597

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.10

1.1

1.0

88.47

81.60

titre

0.18

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

374

1.48

2.10

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

233

1.61

2.08

1.9

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

264

1.57

2.08

1.5

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

207

1679

1.22

2.07

1.1

1.2

114.74

6619.60

iu/ml

0.64

410

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

293

2455

1.18

2.07

1.3

1.6

148.54

134.77

au/ml

1.09

705

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

557

1.38

2.05

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

328

1.51

2.05

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

328

1.51

2.05

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

328

1.51

2.05

1.8

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

519

4541

1.13

2.05

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

795

7129

1.11

2.04

4.4

5.5

5.83

5.84

kpa

0.09

769

6940

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

173

0.40

2.02

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

170

1355

1.24

2.02

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

1.65

2.01

1.0

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

399

3436

1.15

2.00

2.6

3.1

93.89

129.57

ng/l

2.32

345

3052

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4024

38367

1.06

2.00

2.8

2.7

—

estimate

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

193

2302

0.82

1.96

4.3

5.1

1.49

1.72

3.32

182

2171

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

531

1.38

1.91

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

262

1.54

1.91

1.3

1.4

123.00

119.69

nmol/l

0.05

193

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

350

1.47

1.91

1.1

1.2

76.17

72.95

u/l

0.20

320

(3003181) Sodium [Moles/volume] in Urine

122

943

1.28

1.90

1.7

1.9

65.89

69.04

mmol/l

0.27

765

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

122

944

1.28

1.88

1.2

1.3

0.16

0.19

nmol/l

0.59

717

(3001019) Free T4 and TSH panel - Serum or Plasma

718

6438

1.11

1.87

1.7

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

186

1.64

1.87

1.0

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

242

2016

1.19

1.86

2.7

2.8

3.96

2.55

index

0.68

133

1092

(3026008) Bacteria identified in Urine by Culture

2286

21478

1.06

1.86

2.7

2.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

127

1.79

1.85

1.3

1.2

38.32

39.15

g/l

0.11

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

238

1983

1.19

1.84

1.6

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1108

11742

0.92

1.83

1.5

1.6

982.23

1007.81

mu/l

0.41

933

10156

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

172

1.66

1.83

1.7

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

103

784

1.30

1.82

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

237

1977

1.19

1.81

5.5

6.8

1055.64

556.00

iu/ml

0.48

242

(3044009) aPTT.lupus sensitive (LA screen)

1.91

1.77

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

144

1.71

1.76

2.0

2.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

159

1.68

1.76

1.0

—

(3037121) Protein [Mass/volume] in Urine

303

2593

1.16

1.70

3.4

4.3

364.69

390.46

mg/l

0.12

133

1365

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

254

1.52

1.70

1.1

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

611

1.33

1.70

2.7

2.6

1.61

1.48

g/24h

0.13

378

(3041096) Erythrocytes [Presence] in Urine by Automated

2753

26072

1.06

1.70

2.7

2.8

0.01

0.07

estimate

1.13

766

7676

(3008152) Bicarbonate [Moles/volume] in Arterial blood

276

3140

0.86

1.66

5.7

6.8

24.03

24.25

mmol/l

0.55

262

3005

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

675

1.30

1.64

1.8

1.4

—

21.90

—

(3050794) Legionella sp Ab [Presence] in Serum

2.03

1.64

1.3

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

125

1.74

1.64

1.0

1.8

90.45

50.12

ng/l

0.29

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.54

1.62

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

421

1.38

1.62

1.7

2360.00

2851.53

titre

—

(3044290) Cell count panel - Cerebral spinal fluid

254

2154

1.17

1.62

1.2

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

122

1490

0.80

1.62

1.4

1.5

6.36

6.71

mmol/l

1.07

112

1363

(3022475) Manganese [Moles/volume] in Blood

2.15

1.61

1.4

1.3

0.17

0.16

umol/l

0.17

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1156

10666

1.08

1.61

1.6

1.5

3.49

3.44

mmol/l

0.81

767

6880

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

122

966

1.25

1.60

1.4

1.3

19.38

28.79

u/l

0.92

106

842

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.52

1.59

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

679

6129

1.10

1.59

4.0

5.3

4.80

4.81

kpa

0.05

657

5961

(3000330) Specific gravity of Urine by Test strip

281

3180

0.87

1.59

2.4

2.7

1.02

ratio

0.03

242

2788

(3051611) Lipemic interference index of Serum or Plasma

653

1.30

1.58

3.0

3.5

16.50

15.37

index

0.30

463

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

440

1.37

1.58

1.2

—

(3002619) Bacteria identified in Specimen by Culture

219

1.53

1.58

1.2

—

(4281824) Cell count and differential, peritoneal fluid

732

0.73

1.57

1.1

—

(3020491) Glucose [Moles/volume] in Blood

603

1.31

1.56

1.7

1.5

6.41

6.01

mmol/l

0.49

484

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

510

1.34

1.54

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

172

1419

1.20

1.53

1.3

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

107

840

1.26

1.53

1.5

—

(46236302) HLA-C [Type] by High resolution typing

0.00

1.51

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

1.51

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

1.51

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

1.51

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

1.51

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

121

1.71

1.51

1.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

230

1.50

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

230

1.50

2.0

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

386

1.38

1.49

2.4

2.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.56

1.48

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.86

1.48

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

191

1.55

1.48

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

107

1.75

1.47

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

670

1.28

1.46

1.6

1.7

42.40

52.41

1.44

430

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1476

13792

1.06

1.44

1.8

1.7

3.53

3.45

ratio

1.71

1082

9946

(3033923) Metanephrine [Moles/time] in 24 hour Urine

123

1.68

1.43

1.0

1.1

0.58

0.72

umol/24h

1.05

(3002621) Streptococcal DNAse B [Units/volume] in Serum

154

1.60

1.42

1.2

1.1

298.60

316.05

u/ml

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

382

1.37

1.41

1.9

2.0

1.81

1.37

nmol/l

1.38

305

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.69

1.41

1.0

1.1

21.37

34.29

umol/24h

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

7712

75130

1.05

1.40

15.4

14.8

13.21

13.27

5.78

7645

74118

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

763

1.26

1.39

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

1.64

1.38

1.3

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

178

0.50

1.38

2.2

5.4

6.00

kpa

—

172

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

102

1.74

1.38

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

117

1.69

1.38

1.8

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

119

0.41

1.37

1.6

3.4

5.80

5.16

ug/l

—

119

(3016650) Hepatitis A virus Ab [Presence] in Serum

219

1866

1.16

1.37

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

103

819

1.24

1.35

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

394

1.35

1.1

—

0.13

—

(3025130) Human papilloma virus identified in Specimen

251

2165

1.15

1.33

1.8

1.9

—

(3001729) Color of Synovial fluid

0.00

1.33

0.0

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.91

1.33

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

150

1244

1.19

1.31

1.7

1.8

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.39

1.30

1.3

3.4

4.24

4.66

mmol/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

292

2550

1.13

1.30

1.3

1.6

401.26

459.57

mg/l

1.59

280

2452

(3038071) Oxygen [Partial pressure] in Mixed venous blood

171

0.52

1.28

2.2

5.4

5.37

5.29

kpa

—

171

(3010144) Erythrocytes [#/volume] in Synovial fluid

476

1.31

1.26

1.4

1.5

21723.31

61743.40

e6/l

1.16

331

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

136

1.60

1.25

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

487

0.71

1.25

1.3

62.66

70.67

ug/l

0.70

487

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

647

5903

1.09

1.25

1.4

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

477

1.30

1.24

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

625

1.26

1.24

1.3

1.4

72.67

73.15

0.13

601

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

340

3006

1.12

1.24

4.3

8.5

1.18

1.23

mg/l

0.64

320

2870

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1701

16046

1.05

1.21

2.4

2.3

—

(44806071) Cardiolipin IgM antibody measurement

161

1.53

1.21

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1124

0.81

1.20

2.8

3.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

674

1.25

1.18

1.3

1129.41

969.49

titre

0.55

118

(3020650) Glucose [Presence] in Urine

342

0.66

1.18

1.3

1.5

0.00

0.04

estimate

1.34

342

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

613

1.26

1.17

1.3

1.4

504.95

505.12

mu/l

0.00

589

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

261

1.40

1.16

1.0

809.00

831.55

ng/l

0.14

187

(3002079) Sodium [Moles/time] in 24 hour Urine

431

1.31

1.16

1.5

1.3

154.87

159.43

mmol/24h

0.20

431

(3018572) Chloride [Moles/volume] in Blood

1074

0.82

1.14

4.8

7.4

105.73

105.37

mmol/l

0.34

965

(3039000) Anion gap in Blood by calculation

1073

0.82

1.13

4.8

7.4

11.80

11.36

mmol/l

0.74

964

(21491868) Cryoglobulin [Mass/volume] in Serum

296

1.37

1.13

1.0

1.2

—

0.14

g/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.46

1.13

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

263

1.39

1.12

1.0

40.08

38.91

ng/l

0.07

192

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.78

1.10

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

654

6007

1.08

1.10

1.5

1.17

1.15

ratio

0.15

382

3607

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

549

1.26

1.09

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

549

1.26

1.09

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

549

1.26

1.09

1.6

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

123

1023

1.19

1.09

1.2

32.63

37.47

mg/l

0.99

102

860

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

290

1.36

1.08

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

290

1.36

1.08

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

290

1.36

1.08

1.1

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

138

1160

1.18

1.08

1.1

—

18.47

—

(3044007) Cell count panel - Peritoneal fluid

162

0.55

1.08

2.2

2.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

274

1.37

1.07

2.3

2.5

1.70

1.57

mmol/l

0.13

204

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

116

962

1.19

1.06

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

161

1373

1.16

1.06

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

116

963

1.19

1.05

1.1

1.4

78.64

76.44

0.12

(3001686) Cold agglutinin [Titer] in Serum or Plasma

119

1.57

1.05

1.5

1.4

—

137.27

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

473

1.27

1.05

1.9

1.8

2.92

3.31

mg/l

0.39

458

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1041

0.82

1.05

1.9

4233.08

964.26

pmol/l

0.43

139

(3051387) C reactive protein [Mass/volume] in Capillary blood

175

1503

1.15

1.05

3.1

21.84

24.55

mg/l

0.51

104

990

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

157

1784

0.87

1.04

3.5

3.8

109.15

1074.62

u/ml

1.05

136

1538

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.84

1.03

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.90

1.02

2.5

2.1

220.60

271.37

ug/l

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.73

1.02

1.1

—

3.25

—

(3003694) ABO and Rh group [Type] in Blood

2975

30118

0.96

1.01

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

654

6029

1.07

1.01

1.5

1.20

1.19

ratio

0.11

386

3658

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

654

6029

1.07

1.01

1.5

0.96

0.94

ratio

0.29

382

3629

(3034988) Calcium [Moles/volume] in Capillary blood

174

0.57

1.00

1.2

5.2

1.22

1.20

mmol/l

—

161

(44790049) Parainfluenza type 3 nucleic acid detection

131

1107

1.17

0.99

1.5

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

131

1107

1.17

0.99

1.5

1.7

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

170

1.45

0.98

1.0

1.1

—

(44806118) Parainfluenza type 4 nucleic acid detection

131

1108

1.17

0.98

1.5

1.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

131

1108

1.17

0.98

1.5

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3544

34142

1.04

0.96

3.2

0.02

0.11

estimate

0.77

757

7781

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

118

992

1.17

0.95

1.1

215.87

222.47

mg/l

0.22

103

885

(3008295) Osmolality of Serum or Plasma

101

838

1.19

0.95

2.5

1.8

282.63

284.78

mosm/kgh2o

0.45

651

(3013762) Body weight Measured

0.00

0.94

0.0

1.2

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.94

0.0

1.8

—

0.12

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

0.93

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.83

0.92

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

361

1.28

0.90

1.1

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

405

1.27

0.90

1.2

85.95

86.85

u/l

0.02

352

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1425

13502

1.05

0.89

2.2

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

145

1250

1.15

0.87

1.9

1.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

820

1.18

0.86

1.7

1.9

91.63

91.07

0.71

809

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.72

0.86

1.1

2.7

2.90

3.24

pmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

144

1618

0.88

0.86

1.5

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.97

0.85

2.2

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

484

0.77

0.84

3.0

97.25

75.61

mg/l

0.18

365

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

114

969

1.16

0.83

1.3

1.5

—

(3034614) HLA Ag [Interpretation]

1.91

0.83

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.59

0.83

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

863

0.83

9.3

13.1

0.56

0.60

mmol/l

0.81

796

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

281

2528

1.10

0.82

1.9

2.0

1.36

1.37

g/l

0.06

243

2196

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

685

6380

1.06

0.82

1.5

60.17

62.23

ug/l

0.50

589

5416

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.64

0.81

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

254

2279

1.10

0.80

1.2

1.6

3.48

3.59

mmol/l

1.68

243

2160

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

342

1.27

0.79

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

342

1.27

0.79

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

278

0.71

0.79

1.7

2.3

9.41

7.86

mmol/l

0.35

278

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.67

0.78

1.1

1.40

1.69

umol/24h

0.60

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.78

1.4

2.1

0.64

0.88

u/field

0.26

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.51

0.78

1.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

352

1.26

0.78

1.4

1.6

1.13

3.69

u/field

2.51

259

(3016502) Oxygen saturation in Arterial blood

590

5486

1.06

0.76

7.9

9.8

95.57

96.21

1.06

569

5311

(42870560) Thyrotropin [Units/volume] in Cord blood

328

1.26

0.74

1.0

9.24

8.70

mu/l

0.18

273

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

351

3210

1.08

0.73

9.2

11.9

16.62

16.29

1.28

342

3101

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

314

2860

1.08

0.73

1.9

2.2

30.02

3.79

iu/l

0.49

121

1302

(3050129) First trimester maternal screen panel - Serum or Plasma

748

7743

0.95

0.72

1.4

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

1.97

0.72

1.4

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.73

0.70

1.1

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.56

0.70

2.9

3.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

710

1.17

0.70

1.2

1.1

1.05

ratio

0.00

600

(3045142) Bone marrow Pathology biopsy report

665

1.17

0.69

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.68

0.69

3.7

4.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

503

1.20

0.67

1.4

1.6

—

(4133840) Spirometry

245

1.29

0.67

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

521

0.81

0.66

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

677

1.17

0.66

1.4

1.44

1.39

nmol/l

0.15

611

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

312

2856

1.08

0.66

1.6

0.43

0.42

nmol/l

0.04

244

2285

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

442

1.21

0.65

1.8

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

398

1.21

0.64

1.2

12.87

20.52

u/l

1.21

343

(3004451) EKG impression Narrative

256

1.27

0.64

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

160

1745

0.90

0.64

4.0

5.6

1.16

1.24

mmol/l

0.88

141

1537

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

363

1.22

0.63

1.4

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

390

1.21

0.63

1.0

1.1

23.50

153.08

ng/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.70

0.63

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

153

1.35

0.62

6.8

4.4

—

(21494434) Karyotype in Bone marrow

482

1.19

0.61

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

464

1.19

0.61

1.5

—

(40768795) Lymph node Pathology biopsy report

675

0.85

0.61

1.2

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

175

1570

1.10

0.60

2.8

4.7

1268.00

961.35

u/ml

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.60

0.0

1.2

—

1.57

—

(3017509) Phencyclidine [Presence] in Urine

206

1.29

0.60

1.5

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

341

3148

1.07

0.59

1.3

3.86

3.83

ug/l

0.02

321

2944

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

110

963

1.13

0.59

1.5

1.7

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.59

0.0

5.9

—

875.27

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

146

1.35

0.59

2.9

2.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

662

6236

1.05

0.58

7.7

9.2

5.08

5.07

kpa

0.11

635

6020

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

480

0.82

0.58

2.4

2.8

53.16

52.21

umol/l

0.07

449

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.52

0.58

1.3

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

662

6237

1.05

0.58

7.7

9.2

13.03

13.70

kpa

2.52

633

6018

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

367

1.21

0.58

1.6

1.9

0.15

0.21

nmol/l

1.12

285

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

453

4716

0.94

0.58

3.4

4.3

5.70

26.18

ug/l

1.84

322

3521

(40761995) Spermatozoa Progressive [#/volume] in Semen

479

0.82

0.57

3.6

3.1

48.58

44.48

0.70

479

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

479

0.82

0.57

7.2

6.3

8.15

8.88

0.43

479

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.44

0.57

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

119

1049

1.12

0.57

1.6

1.9

1.59

1.72

mmol/l

1.12

119

1029

(3010015) Selenium [Moles/volume] in Serum or Plasma

190

1.30

0.57

1.8

2.6

1.27

1.20

umol/l

0.82

157

(3003396) Base excess in Arterial blood by calculation

658

6203

1.05

0.57

7.7

9.1

0.53

0.63

mmol/l

0.36

557

5017

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.69

0.57

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

432

1.19

0.56

1.2

—

(3042733) HLA Ab [Presence] in Serum

358

0.80

0.55

6.8

4.5

—

(3019150) Specific gravity of Urine by Refractometry

2039

20557

0.97

0.55

3.2

3.3

1.02

1.33

kg/l

1.34

1275

12987

(3019977) pH of Arterial blood

663

6257

1.05

0.55

7.7

9.2

7.42

0.76

293

3290

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.42

0.55

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

131

1.36

0.55

1.2

1.3

99.83

85.46

umol/l

0.38

122

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

577

5430

1.05

0.54

2.5

82.75

78.45

ml/min/173m2

2.00

273

2111

(3035880) pH of Pleural fluid

140

1.34

0.54

1.2

1.3

7.45

7.39

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.56

0.53

1.0

—

28.30

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.52

0.52

2.2

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

212

0.74

0.52

1.7

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

336

1.20

0.52

1.2

1.4

17.13

16.78

umol/l

0.21

296

(3029612) Listeria sp Ab [Titer] in Serum

1.52

0.52

1.2

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.41

0.51

3.3

3.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

565

1.15

0.51

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

359

3745

0.94

0.51

4.5

4.4

134.31

132.34

g/l

1.01

349

3656

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

556

1.15

0.51

2.8

3.3

127.24

141.20

au/ml

0.09

(40757373) Influenza virus identified in Isolate

116

1.36

0.50

1.8

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

230

2112

1.08

0.50

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

151

1.31

0.49

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.49

0.49

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

265

0.78

0.49

2.5

2.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

519

5352

0.95

0.49

2.1

2.4

0.22

0.31

e6/l

1.61

489

5057

(40758292) HTLV I+II Ab panel - Serum

222

1.24

0.49

1.5

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

403

1.17

0.48

1.3

6.18

6.03

mmol/l

0.18

375

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

187

1.27

0.48

1.2

1.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

126

1.33

0.47

1.4

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

450

1.16

0.47

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

488

0.85

0.47

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.47

0.47

1.6

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

335

3485

0.95

0.45

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

154

1.28

0.44

1.6

1.7

19.67

17.11

nmol/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

495

0.86

0.44

6.0

7.8

12.67

77.48

ug/l

0.95

356

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

389

1.17

0.44

2.3

2.5

164.95

123.20

ng/l

1.62

301

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

172

0.74

0.43

1.8

4.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

344

1.18

0.43

1.2

1.5

13.73

14.28

pmol/l

0.36

291

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

184

1689

1.08

0.42

1.3

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

191

1.24

0.42

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

191

1.24

0.42

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

191

1.24

0.42

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

191

1.24

0.42

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.38

0.41

1.6

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.0

—

0.03

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.1

—

0.15

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

354

0.83

0.41

1.0

1.1

—

7.19

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.49

0.41

1.6

1.2

31.62

29.95

mg/24h

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

264

1.20

0.40

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.40

0.0

1.1

—

210.41

—

(44786800) Granulocytes/Leukocytes in Body fluid

0.00

0.40

0.0

1.2

—

34.45

—

(3019230) Fractional oxyhemoglobin in Venous blood

151

1603

0.93

0.40

7.0

5.2

61.17

63.46

0.64

151

1596

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.40

0.0

1.2

—

1.18

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

384

1.16

0.39

1.4

1.6

7.76

5.84

u/l

0.48

316

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

302

1.18

0.39

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

372

0.85

0.38

6.2

5.8

5640.26

454.08

mg/l

0.44

289

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.37

0.38

1.3

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

248

1.19

0.38

5.3

3.2

1.40

1.14

0.35

248

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.37

0.37

1.8

1.1

0.03

mg/l

—

(3007916) DNA double strand Ab [Titer] in Serum

1.34

0.37

1.2

1.4

—

324.90

—

(3040151) Glucose [Moles/volume] in Capillary blood

808

0.90

0.37

2.5

4.3

7.75

7.11

mmol/l

0.55

675

(40761536) Microorganisms panel - Urine sediment

743

7109

1.03

0.36

3.7

3.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

607

6182

0.97

0.36

2.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.36

0.35

2.5

2.1

5.72

7.57

mmol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.44

0.35

1.3

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.44

0.35

6.5

5.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

810

1.10

0.35

1.3

1.2

0.53

0.67

ratio

5.86

470

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

358

0.85

0.35

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

343

1.15

0.34

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

623

1.11

0.34

4.9

4.3

9.01

9.07

mg/l

0.03

503

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

812

1.09

0.34

1.3

1.7

—

(3012565) Volume of 24 hour Urine

362

1.14

0.34

2.0

2.1

2300.73

1997.61

0.96

341

(3041354) Potassium [Moles/volume] in Venous blood

451

0.87

0.34

1.6

2.2

4.00

3.94

mmol/l

0.45

446

(3023183) Ammonium ion [Moles/volume] in Plasma

148

1559

0.93

0.34

3.1

33.81

34.34

umol/l

0.08

137

1464

(3023410) Appearance of Cerebral spinal fluid

127

1164

1.08

0.34

1.4

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

143

1.24

0.33

1.3

1.16

1.18

mmol/l

0.59

143

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.70

0.33

1.8

2.9

105.83

101.82

g/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

438

1.13

0.32

1.5

1.9

1.84

1.78

u/field

0.04

257

(3035285) Chloride [Moles/volume] in Venous blood

449

0.88

0.32

1.5

2.3

107.40

105.69

mmol/l

2.81

444

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

217

0.82

0.32

1.1

1.03

1.20

mom

0.47

217

(3047189) Immunofixation for 24 hour Urine

180

1.21

0.32

3.0

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2214

21518

1.02

0.32

1.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

126

1.25

0.32

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.35

0.31

1.6

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

254

1.16

0.31

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.30

0.30

1.1

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

404

1.12

0.29

1.3

1.4

134.24

132.59

nmol/l

0.13

404

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

527

1.10

0.29

1.2

11.71

15.22

u/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

137

1.22

0.29

1.2

1.1

—

(40768793) Breast Pathology biopsy report

209

1962

1.05

0.28

1.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

463

4710

0.97

0.28

2.5

2.8

29.12

42.40

u/ml

1.76

449

4567

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

0.83

0.27

1.3

4.5

11.11

kpa

0.00

191

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

0.83

0.27

1.3

4.5

4.82

4.79

kpa

0.08

191

(4034850) Laboratory test

221

2082

1.05

0.27

7.0

7.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

240

2266

1.05

0.26

1.3

1.7

14.20

25.42

e6/l

0.94

177

1656

(40765089) Chromosome analysis panel - Blood by G-banded

741

1.08

0.25

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

214

2203

0.96

0.25

1.4

67.42

105.68

pmol/l

1.90

208

2144

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

149

1.19

0.24

1.2

1.8

3.16

3.70

ug/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

582

5880

0.97

0.24

7.5

9.4

7.10

7.23

mmol/l

0.22

558

5690

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

220

0.85

0.24

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

112

1172

0.94

0.24

2.3

2.5

60.91

132.64

ug/min

1.66

757

(3017704) Immunofixation for Urine

214

1.15

0.24

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

124

0.79

0.24

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

878

1.07

0.23

1.6

1.5

1.28

1.29

promille

0.03

680

(3009466) Valproate [Moles/volume] in Serum or Plasma

130

1352

0.95

0.23

5.6

6.1

374.07

383.93

umol/l

0.37

118

1207

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

158

1634

0.95

0.23

1.6

7.46

7.58

mmol/l

0.36

153

1575

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

250

0.87

0.23

2.7

0.61

mmol/l

0.14

250

(40768806) Pleura Pathology biopsy report

318

1.12

0.23

1.7

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

100

928

1.06

0.22

1.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

1240

12406

0.98

0.22

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

518

1.09

0.22

1.4

1.7

39.65

38.10

0.10

320

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

496

0.91

0.21

1.3

57.20

76.03

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

1.0

—

1.10

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.4

—

203.00

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

434

0.91

0.21

1.6

2.3

1.20

mmol/l

0.01

429

(3013336) Amino acids [Identifier] in Serum or Plasma

124

1.19

0.21

2.3

2.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

100

0.79

0.21

1.5

3.4

866.50

3056.77

u/l

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

102

0.77

0.21

1.3

1.4

66.38

55.20

—

(3028717) Thiamine [Mass/volume] in Blood

143

0.83

0.21

1.3

59.92

64.69

ug/l

0.35

143

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

115

1.20

0.21

2.9

5.7

29.80

40.64

ug/min

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

464

0.91

0.21

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

170

1606

1.04

0.20

1.7

2.8

0.92

0.82

nmol/l

0.90

143

1397

(3047185) IgG [Mass/volume] in Urine

0.00

0.20

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

637

0.93

0.20

3.3

3.2

—

(3024471) HLA-A [Type]

330

0.90

0.20

1.0

—

(40768800) Prostate Pathology biopsy report

444

1.09

0.20

1.2

—

(4024509) Urine culture

344

3296

1.03

0.20

2.1

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

3.1

—

0.59

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

163

0.85

0.19

1.6

5.6

1.22

1.21

mmol/l

0.69

150

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

241

2297

1.04

0.19

1.3

1.8

394.23

2815.99

e6/l

0.81

190

1778

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

594

0.93

0.19

1.1

1.2

—

(3004775) Volume in Urine collected for unspecified duration

359

0.91

0.19

1.8

2.5

661.74

619.62

0.26

273

(3013727) Leukocytes other/Leukocytes in Blood

200

1.13

0.19

5.7

3.6

45.93

48.11

0.19

195

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

247

1.12

0.19

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

131

1234

1.05

0.19

1.6

1.4

38.32

35.24

nmol/l

0.51

123

1138

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

319

3232

0.97

0.18

4.7

4.4

1.31

1.33

0.14

319

3215

(3024932) HLA-DR beta [Type]

327

0.90

0.18

1.0

1.1

—

(3016750) Collection duration of Urine

296

0.90

0.18

1.6

2.4

512.84

507.44

min

0.08

239

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.17

0.17

1.6

1.4

335.01

557.26

nmol/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

520

0.93

0.17

2.5

3.1

110.29

178.22

umol/l

1.45

273

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

140

0.84

0.17

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.13

0.17

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

919

1.05

0.17

3.1

3.9

155.73

579.73

u/ml

0.81

843

(3028308) Erythrocytes [#/volume] in Pleural fluid

344

1.09

0.17

1.6

1.5

9460.19

60666.08

e6/l

1.40

183

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

517

4998

1.02

0.17

1.1

1.52

g/l

0.12

517

4992

(3006576) Bicarbonate [Moles/volume] in Blood

181

0.87

0.16

4.0

6.5

23.11

24.65

mmol/l

1.13

174

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

579

0.94

0.16

1.3

1.1

9.45

8.54

mm/h

0.34

579

(40761539) Cells [Type] in Urine sediment by Light microscopy

156

1.14

0.16

1.4

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.77

0.15

1.0

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

317

3199

0.98

0.15

4.9

4.3

0.66

0.62

1.09

317

3187

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

194

1854

1.03

0.15

1.6

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

251

1.10

0.15

1.1

—

(4038314) Semen analysis, post vasectomy

138

1.14

0.15

1.1

1.2

—

(3006598) pH of Arterial cord blood

280

1.09

0.15

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.80

0.14

1.3

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

0.79

0.14

1.3

1.4

23.43

30.34

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

0.78

0.14

1.3

1.4

4.43

3.26

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

483

1.06

0.13

1.0

101.40

91.98

1.29

391

(21494814) CD8 cells/Lymphocytes in Specimen

330

1.08

0.13

2.3

2.4

27.67

30.01

0.57

330

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

378

1.07

0.13

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

430

4166

1.02

0.13

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

822

1.04

0.13

6.9

7.7

10.66

10.64

mg/l

0.01

771

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

513

4981

1.02

0.12

3.1

3.7

1.23

mmol/l

0.57

440

4326

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

185

1872

0.97

0.12

1.7

2.0

1.17

1.89

ug/l

1.46

160

1684

(40765096) Chromosome analysis panel by Banding

188

1.10

0.12

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

303

1.07

0.11

1.1

1.0

19.18

19.96

mmol/l

0.91

284

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

380

1.06

0.11

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

113

1.13

0.11

2.5

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

333

1.07

0.11

1.9

2.1

95.92

93.09

ng/l

0.06

333

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7814

77140

0.99

0.10

15.7

14.9

333.83

333.54

g/l

2.21

7772

76694

(3036180) Methadone [Presence] in Urine

1.12

0.10

2.8

2.2

—

(3010937) Rubella virus Ab [Presence] in Serum

115

1.11

0.08

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

142

0.90

0.08

1.4

5.57

5.49

mmol/l

0.13

142

(3027035) Albumin [Mass/time] in 24 hour Urine

1.02

0.08

2.2

1.2

—

551.42

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

535

5219

1.01

0.08

8.4

10.0

124.67

123.33

g/l

0.79

526

5105

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

155

1496

1.02

0.08

3.8

6.2

0.36

0.33

iu/ml

0.66

804

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

202

1.07

0.08

1.0

8.79

6.42

u/ml

0.31

202

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.81

0.07

1.5

224.83

304.21

umol/24h

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

141

0.91

0.07

1.0

1.1

—

(40768441) Liver Pathology biopsy report

649

1.03

0.07

1.2

1.6

—

(3024928) Oxygen saturation in Venous blood

185

1792

1.02

0.07

6.2

5.1

62.66

64.10

0.39

177

1745

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

222

1.07

0.07

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.87

0.07

9.1

7.8

5.79

5.96

mmol/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.86

0.06

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

492

4807

1.01

0.06

1.1

0.61

0.62

ratio

0.10

444

(3042111) Morphology [Interpretation] in Bone marrow Narrative

817

1.03

0.06

1.6

2.0

—

(4035726) Immunohistochemistry procedure

549

5455

0.99

0.06

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

968

0.98

0.06

1.8

1.9

—

(3034426) Prothrombin time (PT)

340

1.04

0.06

1.2

27.92

28.18

0.14

340

(3045788) Cell count panel - Pleural fluid

350

1.04

0.06

1.7

1.5

—

(4198724) Urine methamphetamine measurement

936

1.02

0.05

2.1

2.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

520

5087

1.01

0.05

1.1

0.87

0.88

g/l

0.56

520

5078

(3012441) Differential panel - Pleural fluid

341

1.04

0.05

1.6

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

587

0.97

0.05

1.3

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

665

1.02

0.04

2.7

2.4

36.53

25.25

mg/l

0.94

452

(3006442) Creatine [Moles/volume] in Serum or Plasma

499

1.03

0.04

1.3

1.4

77.23

73.57

umol/l

0.41

499

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

933

0.98

0.04

3.6

4.9

77.76

104.20

u/ml

0.21

345

(3005033) Fetal Nuchal fold Thickness US

490

4801

1.01

0.04

1.5

1.26

0.01

361

3567

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

236

1.04

0.04

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

295

1.04

0.03

1.5

1.6

4.00

5.18

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

501

4915

1.01

0.03

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

198

1.05

0.03

1.8

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

186

0.95

0.03

2.6

2.2

2.44

2.97

ug/l

0.58

175

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

130

1.06

0.02

1.1

1.2

222.68

153.42

mg/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

404

0.98

0.02

1.6

1.4

2149.58

2797.94

e6/l

0.38

265

(3042517) Benzodiazepines panel - Urine

245

0.97

0.02

2.5

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

511

0.98

0.01

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

165

1616

1.01

0.01

2.5

2.6

33.66

32.64

iu/ml

0.02

(3022229) Phosphate [Moles/volume] in Urine

190

1.04

0.01

3.8

3.0

26.94

20.40

mmol/l

1.31

174

(3016273) Islet cell 512 Ab [Units/volume] in Serum

141

1.05

0.01

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

125

0.95

0.01

1.2

1.5

—

(40768446) Kidney Pathology biopsy report

402

0.98

0.01

1.8

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

243

0.97

0.01

1.3

1.8

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

117

1.01

0.00

1.5

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

369

0.99

0.00

1.6

1.8

—

(3016228) CD19 cells/cells in Blood

324

1.00

0.00

2.3

8.09

9.23

0.43

316

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

232

1.02

0.00

2.1

2.3

2.10

1.65

ratio

0.97

224

(3027456) Digoxin [Moles/volume] in Serum or Plasma

430

1.01

0.00

3.5

3.3

0.75

0.81

nmol/l

0.31

346

(3017569) Oxygen content in Arterial blood

235

1.01

0.00

1.7

2.4

16.02

16.52

0.33

235

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

229

0.99

0.00

3.1

2.9

27.61

29.20

umol/l

0.27

158

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

492

1.00

0.00

2.5

2.9

44.25

43.79

0.08

261

(3027273) Bicarbonate [Moles/volume] in Venous blood

244

2402

1.00

0.00

3.0

3.8

25.38

25.11

mmol/l

0.70

229

2305

(3032352) Blasts [#/volume] in Cerebral spinal fluid

128

1.00

0.00

1.2

4.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

660

1.00

0.00

1.2

1.1

1.01

1.05

u/l

0.23

250

(3000012) Reticulocyte production index

639

1.00

0.00

1.6

2.1

0.93

0.92

0.06

394

(3003434) Protein [Mass/volume] in Pleural fluid

416

1.00

0.00

1.5

37.29

35.74

g/l

0.38

377

(3012898) Urea [Moles/volume] in Urine

1.02

0.00

1.9

1.7

220.70

178.53

mmol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

509

5012

1.00

0.00

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

144

1.03

0.00

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

153

0.97

0.00

1.4

1.2

—

(3024263) Appearance of Synovial fluid

278

0.99

0.00

1.7

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.88

-0.00

1.2

—

0.78

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

55.26

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.94

-0.00

1.2

—

(3007463) Buprenorphine [Presence] in Urine

0.91

-0.00

4.1

5.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

2.06

—

(3051101) Glucose [Moles/volume] in Cord blood

0.88

-0.00

1.8

4.8

6.38

8.69

mmol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.96

-0.00

2.7

1.8

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.90

-0.00

1.3

1.7

—

(3049233) Organic acids panel - Urine

0.96

-0.00

1.0

1.2

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.99

-0.00

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.90

-0.00

1.0

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.15

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

25.71

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.90

-0.00

1.0

1.1

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

-0.00

0.0

12.8

—

5.42

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

36.71

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint POLLENALLERG and mortality.

Females

Parameter	HR [95% CI]	p-value
POLLENALLERG	0.829 [0.7, 0.98]	0.031
Birth year	0.998 [0.99, 1.01]	0.672

During the follow-up period (1.1.1998 — 31.12.2019), 503 out of 42785 females with POLLENALLERG died.

Males

Parameter	HR [95% CI]	p-value
POLLENALLERG	0.69 [0.59, 0.81]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 571 out of 48491 males with POLLENALLERG died.

Mortality risk

Mortality risk for people of age

years, who have POLLENALLERG.

N-year risk	Females	Males
1	0.073%	0.129%
5	0.511%	0.928%
10	1.317%	2.246%
15	2.714%	4.4%
20	4.576%	7.364%

Relationships between endpoints

↥

Index endpoint: POLLENALLERG – Pollen allergy

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pollen allergy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints